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 SUMMARY 
 
Antimicrobial agents are an integral part of daily life and in most instances, misused by the 
consumer. This, combined with the inherent ability of microorganisms to rapidly develop 
resistance mechanisms, has led to the emergence and spread of multi-drug resistant pathogenic 
infections. For this reason, there is a great need for novel antimicrobial scaffolds to overcome 
the resistance posed by these microbes. The advent of nanotechnology provides an attractive 
avenue for the development of new or improved antimicrobial compounds. In this regard, metal 
nanoparticles such as silver, produced through nanotechnology have received increased 
attention as potential candidates for antimicrobial development. Consequently, concerted 
efforts have been extended to identify novel biological capping structures that could potentially 
increase the bioactivity of the produced particles. With this in mind, the current study was 
undertaken to explore the use of medicinal plant and bacterial extracts in silver nanoparticle 
production using a green synthetic method. With the use of sunlight, a recently reported primary 
energy source for nanoparticle synthesis, silver nanoparticles were prepared successfully from 
both extracts with attractive reaction times. Moreover, the derived nanoparticles were consistent 
in terms of their spherical shape and small size, both of which are advantageous physical 
attributes that contribute to enhanced bioactivity. Importantly, biomolecules present in the 
extracts displayed a dual functionality of reducing and stabilising produced nanoparticles. For 
the plant extracts, phytocompounds such as flavones; terpenoids and polysaccharides were 
detected in nanoparticle formation whilst in bacterial extracts protein functional groups were 
observed. Bioactivity screening revealed that silver nanoparticle preparations from both phylum 
extract type’s exhibit promising antibacterial and antifungal activities. These results seemingly 
suggest that AgNPs produced in this study represent potential in the development of novel 
antimicrobial agents. Furthermore, the use of sunlight to drive nanoparticle formation is an 
attractive strategy that may be applied as an alternative energy source for future nanoparticle 
preparations.  
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1.1  INTRODUCTION 
The interest in silver nanoparticles (AgNPs) as an alternative to current antibiotics has 
increased profoundly over the last few years. This is owed to the cumulative incidence of 
microbial drug-resistant infections and the lack of appropriate treatment thereof (Ventola, 
2015). The World Health Organisation report of 2014, highlighted the probability of a 
post-antibiotic era in which common infections and minor injuries could potentially result 
in fatalities (World Health Organisation, 2014). Accordingly, concerted efforts have been 
extended by global pharmaceuticals to formulate new or improved antibiotics. However, 
despite high research cost-intensive investment in the last decade or so only two new 
classes of antibiotics have been introduced into the market (Projan, 2003, Walsh, 2003). 
The imperative need for the uncovering of novel antimicrobial scaffolds has led to the 
resurgence of silver, however, in its nano-particulate form (Rai, et al., 2009). 
The antimicrobial activities of AgNPs are well established and currently researchers are 
striving to develop greener synthetic strategies for their production (Ahmed, et al., 2016, 
Kim, et al., 2007). The use of nanotechnology for the synthesis of AgNPs from 
environmentally compatible bio-materials is evolving into an important branch of science 
and technology (Ponarulselvam, et al., 2012). To this end, a variety biological extracts 
have been explored for the bottom-up synthesis of AgNPs (Velusamy, et al., 2016). 
However, there is an ongoing search to identify novel capping structures for the 
production of AgNPs with increased bio-efficacies. In this context, this dissertation aims 
to derive potentially new promising AgNPs from medicinal plant- and bacterial-based 
extracts in a clean, green and cost-effective manner. 
 
1.2  AIMS OF THE STUDY 
The main aims of the MSc study described within this dissertation are as follows: 
1. Green synthesis of AgNPs capped with phytocompounds extracted from leaves of 
the medicinal tree species Moringa oleifera and their bioactivity evaluation. 
2. Green synthesis of AgNPs from the bacteriocin producer Pediococcus acidilactici 
and non-producer Bacillus subtilis and an evaluation of their antimicrobial 
activities. 
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This dissertation is divided into five chapters of which, the first is this introductory 
Chapter 1. 
In Chapter 2, a detailed literature review is presented encompassing the biological 
synthesis of AgNPs from plants and bacteria and their antimicrobial activities. 
In Chapter 3, aqueous leaf extract samples of the medicinal tree species M. oleifera, were 
employed in the sunlight driven synthesis of AgNPs. The produced AgNPs were 
characterised in terms of their yield, morphology and bioactivity. The novelty aspect of 
this research was the production of M. oleifera leaf derived AgNPs using sunlight 
irradiation as an alternative energy source and characterisation of their bioactivity in 
terms of their minimal inhibitory concentrations. 
The use of sunlight as a promising alternative to drive AgNP formation led to its 
application in AgNP synthesis from bacterial extracts in Chapter 4. Novel AgNPs were 
produced from the antimicrobial peptide producing bacterium P. acidilactici and a non-
producing B. subtilis strain. In addition, the produced AgNPs were characterised in terms 
of their morphology and bioactivity. 
Lastly, Chapter 5 comprises of a general discussion and conclusion along with potential 
ideas for future research. 
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Biological synthesis of silver nanoparticles from plants and 
bacteria and their antimicrobial activities 
 
2  INTRODUCTION 
The antimicrobial potential of silver (Ag) and Ag-based solutions has long been 
established, however, their application was considered obsolete upon the discovery of 
antibiotics (Alexander, 2009, Kim, et al., 2007). In recent years, the developing crisis of 
multi-drug resistant pathogenic infections has led to the resurgence in this metal, 
however, with the use of nanotechnology to generate its nanoparticle form. For this 
reason, tremendous efforts have been extended in nanotechnology, particularly in the 
development of green synthetic strategies for silver nanoparticle (AgNP) production to 
facilitate their use in antimicrobial therapeutic applications. 
2.1  CONVENTIONAL NANOPARTICLE SYNTHETIC STRATEGIES 
Established technologies for AgNP synthesis and other metal preparations can be 
categorised distinctly into two approaches, namely: “top to bottom”, which is normally 
employed by physicists and “bottom to up”, a construction favourite of chemists (Biswas, 
et al., 2012, Thakkar, et al., 2010). Both approaches converge at the nanodimension, but 
vary drastically in the synthetic technology. “Top to bottom” approaches apply various 
physical methods such as grinding, milling, sputtering, evaporation-condensation and 
thermal/laser ablation to break down bulk solid materials to their nanoparticulate form. 
“Bottom to up” approaches entail various chemical and biological methods to synthesise 
nanoparticles by the self-assembly of atoms such as Ag+ into nuclei that further develop 
into nano-sized particles (Ahmed, et al., 2016). 
Important physical “top to bottom” methods for nanoparticle preparation include 
evaporation-condensation and laser ablation techniques (El-Nour, et al., 2010). 
Evaporation-condensation applies a tube furnace at atmospheric temperature wherein 
primary material (metal Ag) contained in a boat; is centred in the furnace and vaporised 
into a carrier gas (Ahmed, et al., 2016). A number of inadequacies have been identified 
with this technique, for example, the furnace occupies a large space, requires high energy 
input whilst raising the environmental temperature around the source material and 
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requires long durations to achieve thermal stability. Additionally, a major drawback to 
this type of synthesis is the resulting imperfections in the surface structure of the derived 
nanoparticles which can ultimately alter their physical properties (Ahmed, et al., 2016, 
Iravani, et al., 2014). In laser ablation, irradiation is used to remove material from a bulk 
metal in solution. The efficacy of this technique and characteristics of nascent particles is 
largely dependent on a number of parameters including the wavelength of the laser, 
duration of laser pulses, laser fluence, ablation duration and the effective liquid medium 
with or without surfactants (Chen and Yeh, 2002, Kim, et al., 2005). An important 
advantage of laser ablation for AgNP preparation is the absence of chemicals in solution 
which could potentially contaminate the nanoparticle preparation (Tsuji, et al., 2002). 
 
Regarding “bottom to up” approaches, wet chemical reduction is the most frequently 
practiced method for nanoparticle preparation (Iravani, et al., 2014) although, several 
other methods have been reported (Amin, et al., 2009, Saion, et al., 2013, Yang and Pan, 
2012, Yin, et al., 2003). As the name suggests, wet chemical reduction involves the 
reduction of a metal salt precursor in aqueous or organic solution. Various organic and 
inorganic compounds successfully utilised as reducing agents in the synthesis of AgNPs 
include: ascorbate; borohydride; citrate; elemental hydrogen; formaldehyde; N-N-
dimethyl formamide (DMF); Tollen’s reagent; and polyethylene glycol blocks (Chou and 
Ren, 2000, Iravani, et al., 2014, Pillai and Kamat, 2004). In addition to reducing agents, 
protective stabilising agents are also included in the reaction solution to prevent 
agglomeration of nascent nanoparticles (Bai, et al., 2007, Kapoor, et al., 1994). With 
stability achieved, this method can be useful for the production of high nanoparticle yields 
with low preparation costs (Song, et al., 2009). However, the efficacy of this method is 
challenged by the potential contamination of nascent nanoparticles by precursor 
chemicals, the use of toxic solvents and the generation of hazardous by-products (Iravani, 
2011, Thakkar, et al., 2010).  
Evidently, the aforementioned physical and chemical methods have certain limitations 
that restrict their use in the preparation of nanoparticles for biological applications (Patra 
and Baek, 2014). In this regard, concerted efforts have been extended to develop 
nanoparticle synthetic strategies that are environmentally sound. Essentially, this would 
entail the use of benign, biotechnological tools and has given rise to the concept of green 
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technology. This technology can best be described as the use of biological routes such as 
plants and microorganisms or their byproducts in the synthesis of nanoparticles (Dauthal 
and Mukhopadhyay, 2016, Patra and Baek, 2014, Rajput, et al., 2016). These bio-inspired 
methods (Fig. 2.1) are not only environmentally welcoming but are cost effective and can 
be easily up-scaled for large productions (Dhuper, et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Different approaches for AgNP synthesis. Adapted from (Ahmed, et al., 2016, 
Mittal, et al., 2013).  
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2.2  BIOLOGICAL AGNP SYNTHETIC STRATEGIES 
As previously eluded, biological approaches for AgNP synthesis employ the use of living 
organisms or their extracts as capping/reducing agents in a synthetic reaction .To date, a 
variety of biological entities have been explored for their Ag+ reducing abilities and 
include viruses, bacteria, plants, algae, fungi, yeast and mammalian cells (Makarov, et 
al., 2014, Mohanpuria, et al., 2008, Pantidos and Horsfall, 2014, Thakkar, et al., 2010, 
Velusamy, et al., 2016). Biological synthesis can be divided into two strategies, 
specifically: bioreduction and biosorption. Bioreduction occurs when metal ions undergo 
chemical reduction into biologically stable complexes. Many organisms have displayed 
dissimilatory metal reduction involving the coupling of reduction with oxidation of an 
enzyme. The resulting stable, inert nanoparticles can then be safely extracted from the 
reaction mixture. Alternatively, biosorption involves the attachment of metal ions onto an 
organism itself, such as on the cell wall. Various bacteria, fungi and plants species express 
peptides or possess modified cell wall structures that are capable of binding metal ions, 
thereby forming stable complexes in the form of nanoparticles (Pantidos and Horsfall, 
2014). 
In this review, the use of plant and bacterial biological material for AgNP synthesis will 
be discussed. For a review on the use of alternative biological entities as AgNP factories, 
studies by the following authors are recommended (Pantidos and Horsfall, 2014, Singh, 
et al., 2016, Velusamy, et al., 2016). 
2.2.1  AgNP synthesis from plants 
Plants have shown the capacity to hyper-accumulate metals as a means to protect 
themselves from insects and herbivores. This observation has paved way for the 
technology known as phytoextraction, wherein plants are employed to extract minerals 
from various groundwater and soil sediments. Major applications of phytoextraction 
include the mining of precious metals from unfeasible ground sites (phytomining), 
stabilisation or recovery of non-naturally occurring contaminants (phytoremediation) and 
the addition of essential metals to growing crops. Interestingly, studies have unveiled that 
metals accumulated by the plant are usually deposited in the form of nanoparticles. This 
has stimulated interest for the use of plants as factories for nanoparticle synthesis 
(Makarov, et al., 2014). Whole plants have been explored for the synthesis of 
nanoparticles when grown on the appropriate metal enriched substrates. Species such as 
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Brassica juncae (mustard greens) and Medicago sativa (alfalfa) have demonstrated the 
ability to accumulate AgNPs. For example, 50 nm sized AgNPs, at a high yield (13.6 % 
of total plant weight) were reported for M. sativa when grown on silver nitrate (AgNO3) 
(Harris and Bali, 2008). Additionally, icosahedral gold nanoparticles of 4 nm size were 
observed in M. sativa and semi-spherical copper nanoparticles of 2 nm size were observed 
in Iris pseudacorus when the plants were grown on gold and copper salt enriched 
substrates, respectively (Gardea-Torresdey, et al., 2002, Manceau, et al., 2008). 
Although whole plants can potentially serve as factories for nanoparticle synthesis, 
several disadvantages have been identified with this technology especially when up-
scaling for industrial applications. For example, physical attributes of nanoparticles such 
as size and shape vary upon the localisation of the particles in the plant due to the 
differences in metal ion content in different plant tissues and the possibility of 
nanoparticle movement and penetration (Gardea-Torresdey, et al., 2002). This 
heterogeneity of important bioactivity-determinants such as size and shape (Jeong, et al., 
2014, Pal, et al., 2007) limit the use of these nanoparticles and especially in applications 
where mono-dispersed nanoparticle preparations are required. Furthermore, recovery of 
nanoparticles from living plants entails laborious extraction, isolation and purification 
procedures and may potentially result in low yields (Makarov, et al., 2014). 
The use of plant broths/extracts in nanoparticle synthesis was introduced by Shanker et 
al., (2003). In their study, compounds responsible for the reduction of metal ions were 
extracted and used in as reducing agents in a synthetic reaction mixture, resulting in the 
extracellular production of nanoparticles (Shankar, et al., 2003). This strategy tentatively 
offers several advantages compared to the use of whole plants. For example, nanoparticle 
formation occurs considerably faster as opposed to whole plants which require diffusion 
of metal ions throughout the plant body. Additionally, the use of extracts would be more 
economical due to the ease of purification (Makarov, et al., 2014).  
This in vitro approach has been actively developed and applied to variety of plant flora 
for the synthesis of AgNPs (Iravani, 2011). Various organ extracts: stem, root, leaf, bark, 
fruit and fruit peel have demonstrated the ability to reduce Ag+. Particularly, biomolecules 
(Fig. 2.2) such as proteins, amino acids, enzymes, polysaccharides, alkaloids, tannins, 
phenolics, saponins, terpenoids and vitamins present in the extracts act as both reducing 
agent and stabilising agents (Ahmed, et al., 2016). 
Chapter 2   Literature Review 
9 
2.2.1.1  Plant metabolites involved in nanoparticle synthesis
 
 
Figure 2.2 Major plant metabolites involved in the synthesis of metal nanoparticles: (A)-
terpenoids (eugenol); (B & C)-flavonoids (luteolin, quercetin); (D)-a reducing hexose with the 
open chain form; (E & F)-amino acids (tryptophan, tyrosine) (Makarov, et al., 2014). 
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Terpenoids are a class of diverse organic polymers manufactured in plants from five-
carbon isoprene units and display strong antioxidant activities. In a previous study by 
Shankar et al., (2003) involving gold nanoparticle synthesis from geranium leaf extracts, 
it was suggested that these polymers were actively involved in the reduction of gold ions 
into stable nanoparticles (Shankar, et al., 2003). Later Singh et al., (2010) reported that 
eugenol, the main terpenoid found in Szyygium aromaticum (clove), played an important 
role in the reducing AgNO3 and HAuCL4. The Fourier transform infrared (FTIR) 
spectroscopy analysis of their study suggests that the dissociation of the proton from the 
OH group in eugenol leads to the formation of intermediate resonance structures which 
are capable of undergoing further oxidation. This latter reaction may be coupled to the 
reduction of Ag+ and subsequent formation of stable AgNPs (Singh, et al., 2010).  
Flavonoids are made up of a large group of polyphenolic compounds containing various 
classes such as anthocyanins, isoflavonoids, flavonols, chalcones, flavones and 
flavanones. There are several functional groups present on flavonoid compounds that are 
able to participate in nanoparticle formation. It has been hypothesised that the 
tautomerization of flavonoids from the enol to keto form releases a reactive hydrogen 
atom that can participate in the reduction of metal ions. For example, studies involving 
AgNP synthesis from Ocimum sanctum extracts indicate that synthesis is likely to be the 
result of tautomerization of the flavonoids luteolin and rosmarinic acid (Ahmad, et al., 
2010). Additionally, some flavonoids can chelate metal ions with their carbonyl groups 
or π-electron. Quercetin is an example of a flavonoid with strong chelating activity 
(Makarov, et al., 2014). These mechanisms may explain the prevalence of flavonoid 
groups adsorbed on to the surface of AgNPs derived in previous studies (Gannimani, et 
al., 2014, Veerasamy, et al., 2011). Further indication of flavonoid involvement in 
nanoparticle synthesis is provided by a study using Lawsonia inermis, in which the 
flavonoid apiin was extracted and successfully employed in the synthesis of gold and Ag 
nanoparticles (Kasthuri, et al., 2009). 
Sugars contained in plant extracts are also capable of inducing nanoparticle formation. It 
is known that monosaccharides in the linear form containing an aldehyde (eg. glucose), 
are capable reducing agents (Makarov, et al., 2014). Monosaccharides harbouring a keto-
group may act as antioxidants upon tautomeric transformation from a ketone to an 
aldehyde (eg. fructose). In this regard, glucose is reportedly more efficient at metal ion 
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reduction than fructose due to the kinetics of tautomerism from a ketone to an aldehyde 
which limits the reducing potential of fructose. Disaccharides and polysaccharides may 
also participate in the reduction of metal ions however, this is largely dependent on the 
ability of their monosaccharide components to take on an open chain configuration within 
an oligomer. Examples include lactose and maltose. In contrast, sucrose is unable to 
participate in metal ion reduction because the linkage of its glucose and fructose 
monomers restrict the formation of open chains. However, when sucrose was placed in 
tetrachloroauric and tetrachloroplatinic acids, nanoparticle formation proceeded 
(Panigrahi, et al., 2004). This may be due to the acidic hydrolysis of sucrose yielding 
glucose and fructose. In general, it is suggested that nanoparticle formation by sugars is 
occurs by the oxidation of an aldehyde group into a carbonyl group which subsequently 
leads to the reduction of metal ions and nanoparticle formation (Shankar, et al., 2003).  
FTIR analysis of plant derived metal nanoparticles have revealed the presence of proteins 
on their surface, suggesting that proteins may also possess metal ion reducing ability. 
However, amino acids have displayed differences in their potential for metal ion reducing 
and binding efficiencies. For example, lysine, cysteine, arginine and methionine have 
been shown to bind Ag+. In a separate study, aspartate was used to reduce tetrachloroauric 
acid forming nanoparticles, whilst valine and lysine did not possess this ability. Amino 
acids capable of binding metal ions are thought to do so through their amino or carboxyl 
groups or through side chain groups: carboxyl groups of aspartic and glutamic acid, 
imidazole ring of histidine, thiol of cysteine, thioether of methionine, hydroxyl group of 
serine; threonine and tyrosine, carbonyl groups of asparagine and glutamine (Makarov, 
et al., 2014). 
Linkage of amino acids in a peptide chain may also affect the ability of individual amino 
acids to bind and reduce metal ions. For example, the R-carbon of amines and carboxylic 
acids in a peptide bond are inaccessible for association with metal ions. However, the free 
side chains of individual amino acids can still participate in binding and reduction of 
metal ions although, this is largely dependent on the amino acid sequence. Tan et al., 
(2010) demonstrated that synthesised peptides derived from amino acids with strong 
binding abilities and high reducing activities displayed lower reduction than expected 
(Tan, et al., 2010). A previous study suggested that protein molecules capable of 
nanoparticle formation display a strong attraction of metal ions to the regions on the 
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molecule responsible for reduction however, their chelating activity is limited (Glusker, 
et al., 1999). It was also suggested that the amino acid sequence of a protein can influence 
the size, shape and yield of derived nanoparticles. For example, the synthetic peptide 
GASLWWSEKL was found to rapidly reduce metal ions forming a large number of small 
nanoparticles (˂10 nm), however, replacement of the N- and C- terminal residues forming 
the peptide SEKLWWGASL led to slower reduction and formation of larger nanospheres 
and nanotriangles (40 nm). These findings seemingly suggest that peptides and proteins 
present in plant extracts probably play a vital role in determining nanoparticle size and 
shape and potentially affect the overall yield of the nanoparticles (Tan, et al., 2010). 
2.2.2  AgNP synthesis from bacteria  
There exists a vast array of literature pertaining to the use of bacteria as factories for 
nanoparticle synthesis (Iravani, 2014, Singh, et al., 2015). Bacteria have a marked 
advantage over other microbial systems such as fungi due to their abundance, rapid 
growth rate, cheap cultivation and the relative ease of their manipulation (Pantidos and 
Horsfall, 2014). Their ubiquitous nature has led to their exposure and proliferation in 
many environmental extremes and ultimately depends on the natural defence mechanisms 
of these microorganisms to resist the effects posed by environmental stresses (Shah, et 
al., 2015). Bacteria have demonstrated these defence mechanisms in a number of non-
optimal growth conditions including environments contaminated with metal ions.  
AgNP synthesis by bacteria can occur intracellularly or by the use of their extracts (Singh, 
et al., 2015). Several studies have reported intracellular synthesis by a variety of bacterial 
species and as similarly reported for the use of whole plants, this technology is associated 
with long duration periods for nanoparticle synthesis. For example Pugazhenthiran et al., 
(2009) reported an incubation time of 7 days for AgNP synthesis from Bacillus sp. 
(Pugazhenthiran, et al., 2009). Kalimuthu et al., (2008) reported a reaction time of 24 
hours for AgNP synthesis by Bacillus licheniformis (Kalimuthu, et al., 2008). Although 
this reaction time was more industrially significant, the authors reported an additional 
extraction to acquire the derived nanoparticles. Synthesis of AgNPs by the use of bacterial 
cell free supernatant (CFS) extracts was reported by Shahverdi et al., (2007). 
Interestingly, nanoparticle synthesis occurred within five minutes of Ag+ coming into 
contact with the CFS (Shahverdi, et al., 2007). Thus, this method presents the greatest 
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potential for industrial production of AgNPs from bacteria. Several other studies have 
reported on the production of AgNPs from bacterial CFS extracts but not at the previously 
stated formation rate (Gurunathan, et al., 2009, Saifuddin, et al., 2009). This seemingly 
suggests that bacterial extracts differ in their metal ion reducing abilities and may require 
an external energy source to accelerate nanoparticle formation. 
2.2.2.1  Bacterial metabolites involved in nanoparticle synthesis 
As previously stated, metal nanoparticle synthesis in bacteria may potentially occur 
through resistance mechanisms attained by these organisms to overcome the toxic effects 
of metals. These strategies include: redox state changes, efflux systems, intracellular 
precipitation, metal accumulation and extracellular formation of complexes (Fig. 2.3) 
(Shah, et al., 2015). In an early study, Slawson et al., (1992) observed that the Ag resistant 
strain Pseudomonas stutzeri AG259, was capable of accumulating AgNPs (35-46 nm) 
within its periplasmic space. The formation of these nanoparticles was thought to have 
occurred by a mechanism involving the NADH-dependent reductase enzyme which 
undergoes oxidation to form NAD+. The lost free electron may potentially reduce Ag+ to 
AgNPs (Slawson, et al., 1992). Later, He et al., (2007) reported that the NADH-
dependent reductase enzyme may similarly participate in the extracellular formation of 
gold nanoparticles by the bacterium Rhodopseudomonas capsulata (He, et al., 2007). 
Other studies have reported nanoparticle formation without the use of biological enzymes. 
Non-enzymatic nanoparticle synthesis by a Corynebacterium sp. was reported by Sneha 
et al., (2010). Organic functional groups present at the cell wall were thought to induce 
metal ion reduction (Sneha, et al., 2010). Sintubin et al., (2009) proposed a two-step 
mechanism for AgNP formation by several lactic acid bacteria, involving biosorption of 
Ag+ on the cell wall which is coupled to the subsequent reduction of these ions to form 
the nanoparticles (Sintubin, et al., 2009). Parikh et al., (2008) identified a gene 
homologue in a Ag-resistant Morganella strain with a 99% nucleotide sequence similarity 
to a periplasmic Ag-binding protein-encoding gene (Parikh, et al., 2008). Johnston et al., 
(2013) further reported the production of a small non-ribosomal peptide, delftibactin by 
Delftia acidovorans which they believed to be associated with a resistance mechanism. 
By producing inert gold nanoparticles bound to delftibactin, gold ions no longer caused 
toxicity to the cells (Johnston, et al., 2013). 
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Figure 2.3 Metabolites and mechanisms involved in AgNP synthesis in bacteria: (a)-uptake of 
Ag+ and activation of reduction machinery; (b)-electron shuttle system involving various 
cofactors and enzymes; (c & d)- intra or extracellular localisation of AgNPs; (e)-electrostatic 
interaction between Ag+ and cell wall peptides/proteins & (f)-extracellular reduction by enzymes 
or other metabolites released in solution (Singh, et al., 2015). 
 
2.2.3  Mechanism of nanoparticle synthesis 
There are three main phases in the synthesis of metal nanoparticles from plants and plant 
extracts. Initially, an activation phase takes place during which metal ions are reduced 
from mono or divalent oxidation states to zero-valent states, followed by nucleation of 
the reduced atoms. This step is immediately followed by a growth phase where small 
neighbouring nanoparticles coalesce into larger particles with greater thermodynamic 
stability while further biological reduction occurs. As growth proceeds nanoparticles 
aggregate to form various shapes such as: cubes, spheres, triangles, hexagons, pentagons, 
rods and wires (Kim, et al., 2010). Lastly, a termination phase follows in which 
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nanoparticles acquire the most energetically favourable conformation, which ultimately 
determines the final shape of the particles (Fig. 2.4) (Si and Mandal, 2007). This step is 
largely influenced by the ability of the plant extract to stabilise the resulting nanoparticles. 
For example, the high surface energy of nanotriangles results in their decreased stability. 
Such nanoparticles would then acquire a more stable morphology such as a truncated 
triangle to minimize Gibbs free energy, unless the stability is supported by the given 
extracts. It can be tentatively suggested that a similar mechanism occurs by the use of 
bacterial extracts since proteins and metabolites may also participate Ag+ reaction as 
previously stated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Schematic representation of nanoparticle synthesis using a plant extract (Makarov, 
et al., 2014).  
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2.3  FACTORS AFFECTING BIOLOGICAL NANOPARTICLES 
A number of controlling factors affect the synthesis and morphology of derived 
nanoparticles. Several researchers have associated these variations with the choice of 
adsorbate and catalyst used in the synthetic process (Ajayan, 2004, Patra and Baek, 2014). 
However, reaction parameters have also been shown to strongly affect the synthesis of 
nanoparticles from biological extracts.  
2.3.1  pH 
Studies have revealed that the pH of a reaction solution strongly influences the formation 
of the produced nanoparticles. Variances in reaction pH tend to induce variability in the 
shape and size of the produced nanoparticles. Lower acidic pH values tend to produce 
larger particles when compared to higher pH values. In a study employing Avena sativa 
(oat) biomass for the production of gold nanoparticles, larger particles (25-85 nm) where 
formed at pH 2 whilst smaller particles (5-20 nm) were formed at pH 3 and 4 
(Armendariz, et al., 2004). The researchers suggested that at pH 2, fewer functional 
groups were available for particle nucleation resulting in aggregation of the particles. A 
similar finding was observed in the synthesis of gold nanoparticles from the bacterium 
Rhodopseudomonas capsulate. At an increased pH of 7, spherical particles in the range 
of 10-20 nm in size were observed. In contrast, lowering the reaction pH to 4 resulted in 
the formation of nanoplates (He, et al., 2007).  
2.3.2  Temperature 
Temperature is an important factor in any synthesis. With respect to nanoparticle 
formulation with the use of biological entities, temperature elevation has demonstrated 
catalytic behaviour by increasing the reaction rate and efficiency of nanoparticle 
formation. For example, a study on the influence of reaction temperature in the synthesis 
of AgNPs from neem leaf extracts suggested that temperature elevation (10-50°C) was 
correlated with enhanced reduction of Ag+ (Verma and Mehata, 2016). It was also noted 
that smaller sized AgNPs were produced at 50°C, similar to the finding of Kaviya et al., 
(2011) in the production of AgNPs from Citrus sinensis peel extracts using varying 
temperatures (Kaviya, et al., 2011). Similarly, this trend was observed in the production 
of AgNPs from the spent culture supernatants of Escherichia coli (Gurunathan, et al., 
2009). The authors tentatively suggested that the increased reaction rate might be due to 
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the effect of temperature on a key enzyme participating in nanoparticle responsible 
synthesis. However, the study importantly revealed that temperature elevation above 60°C 
contrastingly favoured the production of larger sized particles. The reason for this 
observation was reported as follows: at high temperatures, kinetic energy of the molecules 
increase resulting in rapid reduction of Ag+ (facilitating reduction and nucleation), to the 
detriment of secondary reduction on the surface of nascent particles in the growth phase. 
However, higher temperatures beyond the optimum are thought to increase the growth of 
the crystal around the nucleus, resulting in the production of larger particles (Gurunathan, 
et al., 2009, Veerasamy, et al., 2011). 
Temperature has also been demonstrated to affect the structural form of nanoparticles. 
For example, AgNP synthesis using Cassia fistula extracts resulted in the formation of 
Ag nanoribbons at room temperature whilst spherical AgNPs were formed at 
temperatures above 60°C (Lin, et al., 2010). High temperatures in the study were thought 
to alter the interaction of plant biomolecules with the faces of Ag, inhibiting the 
coalescence of adjacent nanoparticles.  
2.3.3  Sunlight irradiation 
Sunlight irradiation, a recently reported primary energy source for nanoparticle 
formation, has been observed to derive AgNPs with desired physical attributes. Recent 
studies on sunlight driven AgNP synthesis using Allium sativum (garlic extract) and 
Andrachnea chordifolia ethanol leaf extract revealed that sunlight rapidly enhanced 
nanoparticle formation to produce spherical AgNPs with average diameters of 7.3 nm and 
3.4 nm, respectively (Karimi Zarchi, et al., 2011, Rastogi and Arunachalam, 2011). In 
addition, this use of sunlight has also been used in AgNP synthesis from Bacillus 
amyloliquefaciens CFS to produce circular and triangular crystalline AgNPs with an 
average diameter of 14.6 nm (Wei, et al., 2012).  
 
2.4  EFFECT OF NANOPARTICLE MORPHOLOGY ON BIOACTIVITY 
A variety of literature reports on the synthesis of AgNPs with differing morphologies. 
Understanding the effects of these morphological characteristics on bioactivity is 
therefore an important consideration when deriving nanoparticles for therapeutic 
purposes.  
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2.4.1  Size 
Characteristically, AgNPs are small in size (1-100 nm) and therefore possess a large 
surface area that facilitates their interaction with bacterial cell membranes (Christian, et 
al., 2008, Pal, et al., 2007). However, it has been suggested that within this confined size 
range, AgNPs present a size-dependent inhibition spectrum. Martinez-Castanon et al., 
(2008) reported that AgNPs of 7 nm in size had minimum inhibitory concentration (MIC) 
values of 6.25 µg ml-1 and 7.5 µg ml-1 for E. coli and Staphylococcus aureus, respectively. 
In contrast, larger nanoparticles (29 nm) capped with the same reducing agent displayed 
higher MIC values for the respective strains (Martinez-Castanon, et al., 2008). These 
results are in accordance with other studies that report nanoparticles of ˂ 10 nm in size 
display improved bactericidal activities (Jeong, et al., 2014, Morones, et al., 2005). 
2.4.2  Shape 
The interaction of AgNPs of varying shapes with E. coli cells has unveiled that shape 
plays an important factor in bioactivity. Pal et al., (2007), reported that at a low Ag 
content of 1 µg, truncated triangular nanoparticles showed nearly complete inhibition of 
E. coli cells, whilst spherical nanoparticles with a total silver content above 12.5 µg 
displayed a reduction in colony forming units. Rod-shaped particles and AgNO3 
presented inferior activities when compared to truncated triangular and spherically shaped 
AgNPs (Pal, et al., 2007).  
Considering these factors and the aforementioned factors affecting synthesis of 
nanoparticles, it can tentatively be suggested that the fine tuning of reaction parameters 
such as pH or temperature may be applied in producing AgNPs with these desired 
physical attributes. However, the use of sunlight irradiation provides a promising 
alternative in this regard. 
2.5  POTENTIAL APPLICATIONS OF BIOLOGICALLY DERIVED 
NANOPARTICLES 
The physiochemical characteristics of metal nanoparticles render them applicable across 
a genre of multi-disciplinary fields for a variety of uses including: catalysis (Crooks, et 
al., 2001); micro-electronics (Gittins, et al., 2000); solar energy conversion (Kamat, 
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2007) amongst many others (Fedlheim and Foss, 2001). They have also been recognised 
for their potential in number of medical applications (Rai, et al., 2016). However, the use 
of nanoparticles derived from physical and chemical synthetic routes raises health and 
toxicity concerns due to the nature of the reaction conditions which may ultimately affect 
the properties of the derived particles (Baker, et al., 2013). 
Biologically derived nanoparticles provide a greener alternative to nanoparticles derived 
from the aforementioned routes since, the synthesis methods used to derive these particles 
are clean and non-toxic (Ahmed, et al., 2016). As a result, they are suitable for a number 
of biomedical applications including: cancer therapy; drug delivery; tumour detection; 
genetic disorder diagnosis; tissue repair; cell labelling; antimicrobial development; 
targeting and immunoassays and yet to be discovered applications (Ahamed, et al., 2010, 
Bhadra, et al., 2014, Huang, et al., 2007, Khlebtsov and Dykman, 2011, Rai, et al., 2016, 
Singh, et al., 2016).  
With respect to biologically derived AgNPs, their major exploitation exists in the 
development of antimicrobial agents due to their renowned microbial inhibitory activities 
and with the current status on antimicrobial drug resistance, these particles are being 
extensively sought after as possible alternatives to antibiotics (Kim, et al., 2007, Rai, et 
al., 2009). Given the nature of this study, the antimicrobial effects of AgNPs will be 
discussed so as to establish their potential in antimicrobial drug development. 
 
2.6  SCREENING OF AGNP ANTIMICROBIAL ACTIVITIES 
There exists an abundance of literature reporting on antimicrobial activities of 
biologically derived AgNPs (Awwad, et al., 2013, Logeswari, et al., 2012, Prasad and 
Elumalai, 2011, Sharma, et al., 2009). Most of these studies utilise the disc diffusion assay 
(Biemer, 1973) or agar well diffusion assay (Perez, et al., 1990) to establish inhibitory 
effects. Positive indication of inhibitory activities are visualised by zones of inhibition on 
a microbial lawn. Veersamy et al., (2011) reported zones of inhibition of S. aureus and 
E. coli to be 15 mm and 20 mm respectively for AgNPs (20 µg ml-1) derived from 
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mangosteen leaf extracts (Veerasamy, et al., 2011). Similarly, Logeswari et al., (2012) 
reported zones of inhibition of AgNPs synthesised from various plant extracts against 
several bacterial strains (Logeswari, et al., 2012). Although diffusion techniques are 
preferred amongst researchers, they seem to be labour-intensive. In addition, many 
researchers do not establish the initial concentration of AgNP solution prior to 
antimicrobial evaluation (Jagtap and Bapat, 2013, Prasad and Elumalai, 2011). Such 
disparities make comparison between published data inapplicable (Allahverdiyev, et al., 
2011).  
Determination of minimum inhibitory concentration (MIC) by the broth microdilution or 
macrodilution method (Eloff, 1998, Schwalbe, et al., 2007) is easy to access and provides 
accurate information with respect to microbial susceptibility. Moreover MIC values are 
reported in various concentration units such as µg ml-1, µg l-1 or ppm thereby facilitating 
comparison between publications (Singh, et al., 2015). These methods are therefore 
attractive for AgNP bioactivity analysis. Furthermore, determination of MICs is an 
important consideration for any therapeutic agent in development to assess their toxicity 
at the specified concentration range.  
 
2.7  MECHANISMS OF AGNP MEDIATED ANTIMICROBIAL 
ACTIVITY  
2.7.1  Bactericidal mechanisms 
As previously mentioned, the antimicrobial effects of AgNPs are well established. 
However, a relatively confined amount of studies have been conducted to elucidate their 
mechanisms of antimicrobial action. These mechanisms are poorly understood and have 
failed to achieve consensus amongst researchers. Despite this, three common mechanisms 
of bactericidal activity have been proposed by various studies. These include the uptake 
of Ag+ (1), generation of reactive oxygen species (ROS) (2) and cell membrane disruption 
(3) (Fig. 2.5) (Marambio-Jones and Hoek, 2010).  
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Figure 2.5 Interactions of AgNPs with bacterial cells: (1) release of Ag+ and generation of ROS; 
(2) interaction with cell membrane proteins; (3) accumulation in cell membrane and disruption of 
permeability; (4) entry into the cell and release of Ag+, leading to generation of ROS and damage 
of cellular DNA. In turn, generated ROS may affect DNA, cell membrane and membrane proteins 
whilst released Ag+ may affect cell membrane proteins and DNA. Adapted from (Marambio-
Jones and Hoek, 2010). 
 
2.7.1.1  Uptake of Ag+ 
Since Ag+ are known to possess antibacterial activities, their release from AgNPs may 
potentially aid to the bioactivity of the nanoparticles. It is therefore fitting to consider the 
mechanistic action of Ag+ on bacterial cells.  
The NADH-ubiquinone reductase has been established as one of major targets for Ag+. 
Specifically the binding of Ag+ to this enzyme may be responsible for their bactericidal 
effect even at minute concentrations (Semeykina and Skulachev, 1990). Later, Dibrov et 
al., (2002) reported the binding of Ag+ to transport proteins leads to the leakage of protons 
and ultimately induces the collapse of the proton motive force (Dibrov, et al., 2002). Such 
interactions with transport proteins may be attributed to the strong affinity of Ag+ to thiol 
groups found on cysteine residues of these molecules (Liau, et al., 1997). Ag+ has also 
been reported to inhibit phosphate uptake and additionally causes an efflux of intracellular 
phosphate (Schreurs and Rosenberg, 1982). It has also been hypothesised that the 
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antimicrobial effect of Ag+ is correlated with the disruption of DNA replication. DNA 
molecules in a relaxed conformation can be replicated effectively. However, when Ag+ 
are present in bacterial cells, DNA molecules enter a condensed form and replicating 
ability diminishes which ultimately leads to cell death (Rai, et al., 2009).   
2.7.1.2  Generation of ROS 
The exposure of bacterial cells to AgNPs leads to the generation of ROS (Ninganagouda, 
et al., 2014). Naturally, ROS are metabolic by-products of respiring beings. Whist low 
levels of these species are skilfully controlled by various antioxidant defence 
mechanisms, high levels of ROS results in oxidative stress which is detrimental to any 
living organism. Metals can serve as catalysts and produce ROS in an oxygen containing 
environment (Stohs and Bagchi, 1995). AgNPs are therefore likely to catalyse reactions 
with oxygen leading to the production of excess free radicals. Kim et al., (2007) 
demonstrated the generation of free radicals from AgNPs by means of spin resonance 
measurements. Toxicity of AgNPs and AgNO3 diminished upon addition of an 
antioxidant suggesting that the mechanism of action against bacterial strains was 
associated with the formation of free radicals from AgNPs. The generation of excess free 
radicals attack membrane lipids resulting in the breakdown of the membrane and also 
cause damage to DNA (Kim, et al., 2007). 
The release of Ag+ from nanoparticles attached to the membrane and nanoparticles inside 
the cell also play a role in the generation of ROS. Ag+ released on the membrane are 
capable of ROS generation by acting as electron acceptors whilst those present inside the 
cell more likely to interact with thiol groups of respiratory chain enzymes as previously 
stated, or scavenging superoxide dismutase enzymes (Park, et al., 2009). The effect of 
ROS scavengers on E. coli cells was reported by Inoue et al., (2002). Specifically ROS 
such as superoxide anions, hydroxyl radicals, hydrogen peroxide and singlet oxygen 
contributed to the bactericidal activity against E. coli (Inoue, et al., 2002). 
2.7.1.3  Cell membrane disruption 
According to literature, the bactericidal effect of AgNPs may also be the result of damage 
to the outer membrane of bacterial cells. Previous studies by Sondi and Salopek-Sondi 
(2004) suggested that treatment of E. coli cells with AgNPs induced changes in the 
membrane morphology (Fig. 2.6a). This resulted in increased membrane permeability 
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and shifts in normal transport through the plasma membrane (Sondi and Salopek-Sondi, 
2004). Morones et al., (2005) hypothesised that these mechanisms could explain the 
number of nanoparticles found inside E. coli cells (Fig. 2.6b). AgNPs with oxidised 
surfaces were also reported to induce the formation of holes on the surface of E. coli cells 
and portions of the cellular surface were observed to be eaten away (Smetana, et al., 
2008). The attachment and penetration of AgNPs has also been observed in P. aeruginosa 
(Fig. 2.6c), V. cholera and S. typhus (Morones, et al., 2005). 
 
 
 
Figure 2.6  Transmission Electron micrographs of (a) E. coli cell after 1 h treatment with 50 µg 
cm-3 AgNPs; (b) E. coli cell after 30 min treatment with 100 µg ml-1 AgNPs (c) P. aeruginosa 
cells after 30 min treatment with 100 µg ml-1 AgNPs (Morones, et al., 2005, Sondi and Salopek-
Sondi, 2004). 
 
 
The mechanism of AgNP adhesion and penetration of bacterial cell membranes remains 
to be elucidated. Literature reports indicate that electrostatic interactions between 
positively charged particles and negatively charged cell membranes is essential for the 
bioactivity of these particles (Hamouda and Baker, 2000, Stoimenov, et al., 2002). 
However, this strategy does not validate the adhesion and penetration abilities of 
negatively charged nanoparticles (Sondi, et al., 2003). The researchers argued that 
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although the particles were negatively charged, interactions between the particles and 
building elements of the membrane are likely to have occurred causing structural changes 
and degradation of the membrane. Morones et al., (2005) proposed that the interaction of 
AgNPs and bacterial membranes could be the attributed to the strong affinity of the 
particles to sulphur containing proteins present on the membrane. These interactions are 
thought to be conserved in the interaction of Ag+ and thiol groups on respiratory enzymes 
and transport proteins (Marambio-Jones and Hoek, 2010, Morones, et al., 2005). 
Sondi and Salopek-Sondi (2004) further reported that damage to E. coli cell membranes 
might also occur due to the incorporation of AgNPs into their membrane structure. 
Scanning electron microscopy revealed the formation of “pits” on the surface of the 
membrane (Sondi and Salopek-Sondi, 2004). Similar findings were observed by 
(Stoimenov, et al., 2002). Amro et al., (2000) additionally reported the formation of 
irregularly shaped “pits” on the outer membrane of E. coli cells through the progressive 
release of lipopolysaccharides molecules. This release of LPS molecules was induced by 
metal depletion in the cells (Amro, et al., 2000). A membrane with such morphological 
changes would display a high increase in permeability, rendering the cell incapable of 
regulating proper transport through the membrane as previously described.  
Although these studies have been conducted on Gram-negative bacteria, AgNPs have also 
been reported to exert inhibitory activities against Gram-positive bacteria which differ 
from their counterparts based on differences on in cell wall structure (Dipankar and 
Murugan, 2012). It can be tentatively suggested that AgNPs may form interactions with 
Gram-positive bacteria through surface proteins present on the cell wall. Once penetrated, 
the mechanisms of bacterial activity are conserved with that of Gram-negative bacteria. 
2.7.2  Antifungal mechanisms 
A relatively confined amount of literature focuses on the mechanisms of antifungal 
activity exerted by AgNPs. However, based on the studies that have been reported, it 
seems that inhibition of fungal growth by AgNPs may be the result of damage to fungal 
cellular membranes.  
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Kim et al., (2009) demonstrated the effect of AgNPs on Candida albicans. Transmission 
electron microscopy (TEM) analysis revealed that the treatment of cells with AgNPs lead 
to the formation of “pits” on the cell membrane which ultimately disrupts membrane 
potential (Kim, et al., 2009). A similar finding was made by Nasrollahi et al., (2011) who 
reported that AgNP incubation with C. albicans led to damage of the cell membrane 
(Nasrollahi, et al., 2011). Endo et al., (1997), reported that disruption of membrane 
integrity inhibits the normal budding process of daughter cells. Therefore the authors 
suggested that AgNPs exert their inhibitory activity by inhibiting the budding of daughter 
cells due to the destruction of the cell membrane (Endo, et al., 1997).  
AgNPs may also disrupt antioxidant defences in fungal cells. Eukaryotic cell studies 
suggest that AgNPs directly interact with gluthathione, gluthathione reductase or 
enzymes responsible for maintaining proper levels of gluthathione (Carlson, et al., 2008). 
With respect to fungal cells, it has been hypothesised that Ag+ largely effect the function 
of membrane bound enzymes such as those in the respiratory chain. It has also been 
reported the exposure of fungal cells to Ag+ led to the loss of DNA replication ability. 
This results in the deactivation of ribosomal subunit protein expression and synthesis of 
non-functional enzymes and cellular proteins (Elgorban, et al., 2016).  
From these findings it can be tentatively suggested that bactericidal mechanisms of 
AgNPs are conserved in their inhibition of fungal cells. In summary, AgNPs exert their 
antimicrobial effects by releasing Ag+, disrupting the cell membrane/wall, generating 
ROS and inhibiting proper DNA replication.  
 
2.8  CYTOTOXICITY OF AGNPS 
The unique physico-chemical and biological properties of AgNPs have extremely 
promising industrial and medical applications, as previously mentioned. However, there 
exists a dearth of knowledge regarding the effects of prolonged exposures to nanoparticles 
on human health and the environment (Ravishankar Rai and Jamuna Bai, 2011). It is 
therefore imperative to establish that the in vitro and in vivo cytotoxic effect of AgNPs in 
mind for therapeutic purposes. 
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2.8.1  In vivo studies  
Human contact with nanoparticles occurs in the form of intravenous injection, oral 
administration, inhalation and dermal contact (Chen and Schluesener, 2008). Injection of 
AgNPs in vivo results in short circulation times and broad tissue distribution. Target sites 
often include the liver (main target), spleen, lungs and kidneys (Ahamed, et al., 2010). 
Inhalation studies suggest that AgNPs become deposited in the olfactory mucosa and 
olfactory nerves which can potentially induce impairment and dysfunction of brain cells 
(Oberdörster, et al., 2004) in addition to immunotoxicity (Rahman, et al., 2009). With 
regard to oral administration, migration of AgNPs to the gastrointestinal tract promotes 
dissolution of the particles which subsequently releases Ag+ (Zhang, et al., 2014). A 
recent study on oral exposure to Ag+ indicated that these ions interact with sulphur leading 
to the formation of sulphur containing Ag granules in the intestinal epithelium 
(Loeschner, et al., 2011). The authors suggested that during intestinal digestion, Ag+ give 
rise to particle formation, possibly in the form of Ag2S or AgCl salt. They further added 
that this formation might influence their uptake and reduce the toxic effects of Ag+, 
however the effects of Ag salts on the intestine are yet to be elucidated (Loeschner, et al., 
2011, Walczak, et al., 2012). Reports on the exposure of workers to low doses of Ag dust 
indicated no significant changes in health status.  
2.8.2  In vitro studies 
Many researchers have demonstrated the cytotoxic effects of AgNPs in vitro, however 
there is still a lack of consistent and reliable data amongst publications. For example, in 
a recent review, Kim and Ryu (2013) attributed oxidative stress, apoptosis and 
genotoxicity to be the main in vitro outcome of AgNP exposure (Kim and Ryu, 2013). 
Later, Gliga et al., (2014) identified a major drawback of this review, highlighting that 
the AgNPs were different in each study, i.e. synthesised by different techniques, of 
varying size distributions and coatings, tested on different cell lines under different cell 
culture conditions and often without the use of appropriate controls (Gliga, et al., 2014). 
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Additionally, Hackenberg et al., (2011) reported cytotoxicity of human mesenchymal 
stem cells at a concentration of 10 µg ml-1 AgNPs (˂50 nm), whereas Samberg et al., 
(2012) reported no toxicity of progenitor human adipose-derived stem cells at 
concentrations up to 100 µg ml-1 AgNPs (10-20 nm) (Hackenberg, et al., 2011, Samberg, 
et al., 2012). To determine the effect of size on cytotoxicity, Liu et al., (2010) compared 
the cytotoxicity of AgNPs ranging in size from 5-50 nm on four different cell lines (A549, 
HepG2, MCF-7 and CGC-7901) and reported that 5 nm AgNPs were most toxic (Liu, et 
al., 2010). On the contrary, Kim et al.,(2012) reported the enhanced release of lactate 
dehydrogenase (LDH) and reduced cell viability in the presence of 100 nm sized AgNPs 
when compared to smaller AgNPs (10-50 nm) (Kim, et al., 2012). It can be noted that the 
variation in parameters in these studies makes it difficult to observe trends and come to 
accurate assumptions. To achieve some consensus in this regard, Gliga et al., (2014) 
studied the cytotoxic effect of varying sized AgNPs capped by various agents on the 
normal bronchial epithelial cell line (BEAS-2B). They reported that 10 nm sized AgNPs 
induced cytotoxicity irrespective of the capping agents, at high concentrations (20-50 µg 
ml-1), whilst larger AgNPs did not display significant cytotoxic effects at all tested 
concentrations. The group additionally reported that at non-cytotoxic concentrations (10 
µg ml-1), significant DNA damage was observed for all AgNPs independent of size and 
coating. In contrast, panda et al.,(2011) reported no genotoxicity of AgNPs capped with 
protein at 20-80 µg ml-1 for 24-55 nm sized particles (Panda, et al., 2011).  
Overall, it is difficult to establish the cytotoxic effect of AgNPs due to the differences in 
nanoparticle synthetic methods, their various sizes and capping agents and lastly the 
diverse evaluation tests used to determine toxicity. In fact, by using different organisms 
and/or culture cells there is no conclusive evaluation of AgNP toxicity (Lima, et al., 
2012). However, bearing in mind the results presented in this review, it can be tentatively 
suggested that smaller sized AgNPs are more cytotoxic than larger sized particles at 
higher concentrations. 
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2.9  SELECTED PLANT AND BACTERIUM USED IN THIS STUDY 
2.9.1   Moringa oleifera 
Moring oleifera LAM is a highly valued tree species belonging the family Moringaceae 
and is commonly referred to as the drumstick or horseradish tree. The species is 
indigenous to northwestern India and southern Asia and is also regarded as an important 
crop in several other countries such as the Philippines, Sudan and Ethiopia (Fahey, 2005). 
In South Africa, the tree is widely distributed and can be locally found in suburbs and 
back yards (Fig. 2.7). It is well known by the Indian community for its drumsticks and 
leaves which are popularly consumed as a vegetable dish (Ramachandran, et al., 1980).  
The leaves in particular are reported to possess several nutritional benefits. Research has 
unveiled that the leaves of M. oleifera contain higher levels of Vitamin A, Vitamin C, 
iron, potassium as well as protein found in carrots, oranges, spinach, bananas, milk and 
eggs (Fahey, 2005). In addition, they are also a rich source of the amino acids lysine, 
methionine, tryptophan and cysteine (Makkar and Becker, 1997). Studies have also 
revealed that woman who consume the leaves show enhanced breast milk production 
(Estrella, et al., 2000). Importantly, the leaves have also demonstrated attractive 
medicinal properties such as anti-oxidizing, anti-hypertension and antimicrobial 
activities. Phytocompounds such as phenolics and carotenoids have been reported in the 
preservation of ghee from animal fats. In addition, antioxidant studies have identified the 
major bioactive compounds of phenolics to be flavonoid groups such as quercetin and 
kaempferol. The antimicrobial constituents of the leaves are yet to be identified (Fahey, 
2005), however leaf extracts of M. oleifera display promising antimicrobial activities 
against microorganisms such as Micrococcus pyogenes, E. coli, P. aeruginosa, 
Salmonella typhimurium, S. aureus as well as Bacillus subtilis (Kumari, 2014, Siddhuraju 
and Becker, 2003).  
In the search for capping agents for AgNP preparation for the purpose of antimicrobial 
application, the leaves of this tree display attractive qualities that make them suitable 
candidates. Previously, AgNPs (57 nm) from the leaves have been prepared in a heat 
driven process. However, their characterisation in terms of their minimal inhibitory 
concentration values remains undetermined. It is therefore fitting to establish these 
concentrations so as to determine their potential in antimicrobial development.  
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Figure 2.7 M. oleifera tree growing in a local suburb. 
 
2.9.2  Pediococcus acidilactici  
P. acidilactici PAC1.0. is a Gram-positive homofermentive microbe belonging to the 
family Lactobacillaceae and is renowned for the production of the antimicrobial peptide 
pediocin PA-1, belonging to class IIa of bacteriocins. Pediocin PA-1 is a small (<10 kDa) 
heat-stable peptide that is produced extracellularly and primarily displays substantial 
inhibition of the pathogenic bacterium, Listeria monocytogenes. However, this inhibition 
spectrum is commonly directed towards several other Gram-positive bacteria. (Eijsink, et 
al., 1998, Ennahar, et al., 1999, Marugg, et al., 1992). It has therefore been actively 
researched for its application in food preservation (Ennahar, et al., 1999). 
In the context of this study, production of AgNPs from a bacterium with such 
antimicrobial potential seems interesting. Particularly, because the peptide is produced 
extracellularly, it may therefore be exploited as a capping agent in AgNP production by 
the use of spent cultures. To the best of our knowledge, production of AgNPs from this 
bacterium has not been reported.  
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2.10  CONCLUSION 
Given the literature presented, it can be concluded that green synthetic strategies by the 
use of plant and bacterial based extracts are promising alternatives for the production of 
AgNPs. However, for the production of AgNPs with enhanced bioactivities, 
morphological characteristics such as size and shape need to be finely tuned. In this 
regard, sunlight constitutes a promising candidate compared to the use of alternative 
reaction parameters. Furthermore, the use of extracts with known medical value provides 
with attractive capping substrates that may potentially enhance the bioactivities if the 
produced particles. 
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3. 1  ABSTRACT 
The increasing incidence of multi-drug resistant organisms has led to the resurgence in 
application of Ag-based compounds. Accordingly, increased efforts have been made in 
the field of nanotechnology to develop silver nanoparticle (AgNP) synthetic strategies 
that are inexpensive and environmentally friendly without the use of hazardous 
chemicals. To this end, sunlight irradiation, a relatively new primary source of energy 
was used instead of heat to drive the synthesis of AgNPs. Biologically-derived capping 
substrates were independently extracted from fresh (F) and freeze-dried (FD) leaf samples 
of the medicinal tree species, Moringa oleifera. Importantly, the extracted substrates 
advantageously displayed a dual functionality by reducing Ag+ as well as stabilising the 
resulting AgNPs. Yield analysis indicated a recovery ranging from 0.81 mg and 0.91 mg 
AgNPs per gram dry mass F and FD leaf tissue, respectively. AgNPs from both sample 
types were consistent in terms of their spherical shape with average diameters of 9 nm 
and 11 nm for F and FD samples, respectively. Fourier transform infrared (FTIR) 
spectroscopic analysis suggested that flavones; terpenoids and polysaccharides 
predominate and are primarily responsible for the reduction and subsequent capping of 
AgNPs. Interestingly, bioactivity screening revealed that AgNPs exhibited broad-
spectrum antimicrobial activity against both bacterial and fungal strains. The results 
suggest that AgNPs derived from M. oleifera leaf extracts exhibit potential for application 
as broad-spectrum antimicrobial agents. 
 
 
Chapter 3  Research Results Ӏ 
40 
3.2  INTRODUCTION 
Nanotechnology is a science centered on atomic, molecular and supramolecular 
molecules aiming to create nano-structures with enhanced functionalities (Roco, 2005), 
and the term nanoparticle describes particulate matter ranging in size from 1-100 nm 
(Christian, et al., 2008). Bearing a nano scale size offers the advantage of having a 
significantly large surface area to volume ratio (Iravani, 2011). Increased surface area, in 
combination with nanoparticle conformation and distribution in solution contribute to 
their enhanced physical and chemical properties which are useful in a variety of fields 
such as antimicrobial development (Rai, et al., 2009), bio-molecular detection, 
diagnostics (Schultz, et al., 2000), catalysis (Crooks, et al., 2001), micro-electronics 
(Gittins, et al., 2000), sensing devices, targeting of drugs to cancer cells (Sengupta, et al., 
2005) and yet to be realised applications (Zhang, et al., 2010). These wide ranging 
applications and the increasing ability to manipulate nanoparticle form and function has 
sparked high interest in nanotechnology over the past decade, particularly in terms of the 
development of efficient and environmentally friendly synthetic methods.  
Conventional physical and chemical methods presently have limited use to prepare metal 
nanoparticles. This to a large extent, stems from the use of hazardous chemicals, which 
may become adsorbed onto the surface of the particles (Bhattacharya and Mukherjee, 
2008). Moreover these methods are associated with high-energy input and costly 
downstream processing (Awwad, et al., 2013). Finally, conventional chemically 
synthesised nanoparticles show decreased stability and statically agglomerate within a 
short period (Kapoor, et al., 1994). 
To date, AgNPs receive the most attention based on their desirable antimicrobial effects 
(Panáček, et al., 2009) and especially with the ongoing emergence of multi drug-resistant 
pathogens. This has propelled an exponential increase in research activities pertaining to 
AgNPs as novel antimicrobial agents. Unlike conventional antibiotics which usually have 
a single mechanism of action, AgNPs display multi-mode structure activity mechanisms 
which importantly reduces the probability rate of microorganisms developing resistance 
(Jung, et al., 2008). This has motivated researchers to formulate greener alternatives for 
AgNP synthesis. 
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Green synthesis is defined as the use of environmentally compatible materials such as 
bacteria, fungi and plants in the synthesis of nanoparticles (Patra and Baek, 2014). These 
attractive green strategies are free of the shortfalls aforementioned for conventional 
synthetic strategies, i.e. they are eco-friendly (Veerasamy, et al., 2011). Green-
synthesised nanoparticles are therefore suitable for pharmaceutical and medical 
applications (Ezhilarasan and Sahadevan, 2011). Additionally, precursor costs are 
generally low, waste products derived from these natural extracts are compatible with the 
environment (Kharissova, et al., 2013), and synthesis can be easily up-scaled for 
increased production (Veerasamy, et al., 2011). Intracellular biosynthesis of 
nanoparticles within plants, bacteria or fungi provides bioactive nanoparticles but at 
relatively slow rates (Nath and Banerjee, 2013). Alternatively, synthesis from 
biologically derived extracts offers several advantages such as rapid synthesis; high yields 
and importantly, the lack of costly downstream processing required to obtain to the 
produced particles (Das, et al., 2014, Gannimani, et al., 2014, Liu, et al., 2005). Hence, 
nanoparticle synthesis from plant extracts tentatively offers a route for large scale 
production of commercially attractive nanoparticles.  
Numerous studies report on the use of plant extracts to synthesise AgNPs with significant 
antimicrobial activities: leaf extracts of Acalypha indica (Krishnaraj, et al., 2010); 
Chenopodium album (Dwivedi and Gopal, 2010); Murraya koenigii (curry leaf) 
(Christensen, et al., 2011); Ocimum sanctum (Tulsi leaf) (Ahmad, et al., 2010); Garcinia 
mangostana (mangosteen leaf) (Veerasamy, et al., 2011); seed extracts of Acacia 
farnesiana (Yallappa, et al., 2013); Macrotyloma uniflorum (Vidhu, et al., 2011); root 
extracts of Trianthema decandra (Geethalakshmi and Sarada, 2012), stem extracts of 
Ocimum sanctum (Ahmad, et al., 2010); and even fruit extracts of Musa paradisiaca 
(banana) peels (Bankar, et al., 2010) and Carica papaya (Jain, et al., 2009). In these 
studies, phytocompounds in the plant extract serve as reducing and/or capping agents in 
the reaction with silver nitrate (AgNO3), a commonly used precursor in AgNP synthesis. 
High concentrations of the active ingredient polyphenol in the plant extracts are said to 
enhance reduction and provide stabilisation of the nanoparticles, preventing 
agglomeration (Kharissova, et al., 2013). 
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Moringa oleifera Lam (drumstick tree) is a tree species indigenous to north-western India 
but is also regarded as an important crop in several other countries such as the Philippines, 
Sudan and Ethiopia. The tree is also widely distributed in tropical Asia, West, East and 
South Africa (Fahey, 2005, Siddhuraju and Becker, 2003). It belongs to the genus 
Moringa and the family Moringaceae (Kumari, et al., 2006), and is highly sought after 
for its tender pods, flowers and leaves, all of which are safe for human consumption 
(Ramachandran, et al., 1980). The leaves, in particular, are recognised for their natural 
healing properties and are popularly consumed in a variety of ways (Kumari, et al., 2006, 
Makkar and Becker, 1997). Research to date has unveiled that extracts prepared from the 
leaves possess high natural antioxidant properties and some antibacterial activity against 
Gram-positive and Gram-negative bacteria (Rahman, et al., 2009, Siddhuraju and Becker, 
2003). 
The present study was conceptualised on the basis that AgNP formulation of M. oleifera 
leaf extract may harbor the potential to increase its antimicrobial range and bioactivity. 
Furthermore, the study compared the yield, physical characteristics and bioactivity 
between nanoparticles synthesised using extracts prepared from freeze-dried (FD) and 
fresh (F) leaf material. The comparison between FD and F leaf extracts was inspired by 
the increasing amount of work being done on AgNP synthesis using either F (Veerasamy, 
et al., 2011) or dry plant material (Prasad and Elumalai, 2011). There are few published 
comparisons on nanoparticle yield, quality and bioactivity for extracts prepared with dry 
and F tissue within individual species. However, using Amaranthus dubius leaf extracts, 
Sigamoney et al., (2016) have recently shown that the nature (dry versus F) of the starting 
plant material can influence the yield, morphology and bioactivity of AgNPs produced 
(Sigamoney, et al., 2016). With their reported medicinal, antioxidant and antimicrobial 
activities, Moringa leaves represent a promising candidate for green synthesis of 
bioactive AgNPs that can be produced in an environmentally friendly manner. 
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3.3  MATERIALS AND METHODS  
All chemicals, solvents and media used in this study were of analytical grade and 
purchased from Merck (Pty) Ltd, South Africa, unless stated otherwise. Antibiotics were 
purchased from Sigma Aldrich, Germany. 
3.3.1  Materials  
Fresh M. oleifera plant material was harvested from the south coast of KwaZulu-Natal 
(GPS co-ordinates: 30°0.51'33"S, 30°54.49'39"E). Leaf material was separated from the 
stems, washed with distilled water and air dried to remove residual debris. A portion of 
the leaf material was placed in a freeze dryer (Edwards Wirsam, England) for ±72 h until 
all moisture was removed. Thereafter it was stored at -16°C for further use.  
3.3.2  Preparation of leaf extract samples  
Methods used for the preparation of leaf extract samples and biosynthesis of AgNPs were 
adapted from Veerasamy et al., (2011). Extracts were prepared using 10 g of FD leaf 
material and the equivalent amount of F leaf tissue (in terms of dry weight), in replicates 
of four. Each replicate was homogenised thoroughly in 50 ml Millipore water (using a 
IKA T25 digital Ultra-Turrax-T 25 D, Germany) and the final volume was adjusted to 
100 ml. Resulting homogenates were transferred to 250 ml Erlenmeyer flasks. Flasks 
were covered with foil and placed on a mechanical shaker (Labcon, Spo-MP8) at 115 
rpm, for 24 h at room temperature. To obtain aqueous extracts, homogenates were 
subjected to vacuum filtration using Whatman No.1 filter paper (Whatman Limited, 
England) (Veerasamy, et al., 2011).  
3.3.3  Synthesis of AgNPs  
An aliquot (5 ml) of aqueous plant extract sample was added to 50 ml of 1x10-3 M aqueous 
AgNO3. To drive AgNP formation the reaction mixtures were exposed to direct sunlight. 
Colour change of the reaction mixtures were monitored to determine nanoparticle 
formation which is indicated by a dark brown colour. Once colour intensities of the 
solutions reached a maximum, the vessels were removed from sunlight and stored in 
darkness at room temperature to prevent agglomeration of the nanoparticles. A 50 ml 
aliquot of AgNO3 containing 5 ml distilled water was processed as described above and 
used as a negative control. 
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3.3.4  UV-Vis Spectral analysis  
Further confirmation of AgNP formation by the reduction of Ag+ from AgNO3 was 
achieved by UV-Vis Spectral analysis. Nanoparticle solutions were diluted 1:2 with 
distilled water (200 μl of nanoparticle sample and 400 μl of distilled water) for these 
measurements and distilled water was used as a blank. Nanoparticle solutions and the 
control were simultaneously analysed: absorbance was scanned from 190-900 nm using 
a UV-Vis spectrometer (Specord 210 Analytikjena, Germany). 
3.3.5  Purification and concentration of AgNPs and leaf tissue  
The purification and concentration of AgNPs from the final reaction mixture was adopted 
from the method available in literature (Dipankar and Murugan, 2012). The 55 ml reaction 
mixture (50 ml AgNO3 + 5 ml leaf extract sample) (n=4) was split into two equal parts 
and transferred to pre-weighed sterile 50 ml centrifuge tubes (United Scientific, South 
Africa). The preparations were then centrifuged at 4000 rpm for 2 h (Eppendorf centrifuge 
5810 R, Germany), at 4°C. Supernatants were discarded and the pellet washed in 10 ml 
of distilled water to remove any contaminating plant material before centrifugation for 1 
h as per the conditions described above. This wash step was repeated twice to remove 
water soluble biomolecules such as proteins and cellular metabolites. One half of each 
replicate was then dried in an oven at 37°C for 24 h to determine the dry mass of the 
AgNPs (difference between mass of tube + nanoparticles, and mass of tube), whilst the 
other portion of each replicate was reconstituted in 1 ml of distilled water. The mass of 
each dried pellet was applied as the equivalent mass of its corresponding reconstituted 
pellet since each replicate was equally split. Thus, the concentration of AgNPs was 
determined on a mg/ml basis. This procedure was also used to determine the dry mass of 
the leaf tissue samples from 5 ml aliquots of the extracts. A comparison of nanoparticle 
yield between F and FD starting material was made using the mass of the AgNPs attained 
on a mg AgNP/g dry mass (DM) basis. Dry AgNP samples were kept at room temperature 
whilst reconstituted samples were stored at 4°C prior to use. 
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3.3.6  Characterisation and analysis of AgNPs 
Characterisation techniques were adopted from Gannimani et al., (2014). Dry 
nanoparticle preparations were used for Scanning electron microscopy (SEM), Energy 
dispersive x-ray (EDX) and Fourier transform infrared (FTIR) spectroscopy analysis 
whereas reconstituted samples were used in Transmission electron microscopy (TEM) 
(Gannimani, et al., 2014).  
3.3.6.1  SEM and EDX analysis  
Morphological characteristics of AgNPs were determined using SEM (FEGSEM Zeiss 
Ultraplus). Purified AgNP mass was placed on a carbon tape stuck to a clean aluminium 
stub. Samples (n=3) were then coated with gold followed by SEM analysis and 
simultaneous EDX analysis at 20 kV to determine elemental composition of the particles. 
AZTEC software (Oxford Instruments NanoAnalysis, Ver 1.2) was used for the analysis.  
3.3.6.2  TEM  
Transmission electron microscopy was employed to determine concise nanoparticle 
characteristics such as shape, size and size class distribution. Reconstituted, pure AgNP 
samples were first sonicated to maintain an even distribution of the nanoparticles in 
solution prior to TEM analysis. Samples (n=3) were prepared by placing a small amount 
of nanoparticle solution onto a carbon-coated copper grid which was then dried under a 
lamp. Sample images were obtained using a JEOL TEM (1010) at an accelerating voltage 
of 100 kV. The sizes of the nanoparticles and data analysis of the sizes was accomplished 
using ITEM (Soft imaging system, Germany Ver 5.0). 
3.3.6.3  FTIR  
The purified dry mass of AgNPs were subjected to FTIR analysis (ALPHA-BRUKER, 
Germany) to identify functional groups capping the surface of the nanoparticles. To 
determine which of these groups belong to the plant, purified leaf tissue samples were 
also analysed. Software used for analysis was OPUS Version 6.5. 
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3.3.7  Biological Assays  
3.3.7.1  Strains  
Varying concentrations of the reconstituted nanoparticle solutions were screened for 
bioactivity against the following strains which were from the American Type Culture 
Collection (ATCC): Staphylococcus aureus (43300); Enterococcus faecalis (5129) 
(Gram-positive); Escherichia coli (35218); Pseudomonas aeruginosa (27853); Klebsiella 
pneumoniae (700603) (Gram-negative); Candida albicans (10231); Candida krusei 
(6258) and Candida parapsilosis (22019).  
3.3.7.2  Antimicrobial agents 
Reconstituted AgNPs derived from FD and F leaf extracts were sonicated to maintain an 
even distribution of the nanoparticles in solution prior to use in the bioassays. Testing 
was conducted in 96-well flat-bottom microtitre plates (Greiner bio-one, Germany) using 
final AgNP and leaf tissue concentrations ranging from 6.25 to 200 µg ml-1. The first row 
(row A) of the plates were reserved for blank/negative and uninhibited growth controls 
as the wells were filled with media only (Mueller Hinton (MH) for antibacterial testing 
and Sabouraud-2% dextrose (SD) for antifungal testing, respectively). Aliquots of 100 µl 
of twofold serial dilutions of AgNPs and leaf tissue (2 x final concentrations) were added 
for analysis. The commercially available antibiotics: neomycin; gentamicin; 
ciprofloxacin hydrochloride (bacteria) and amphotericin B (fungi) were used as positive 
antibiotic controls and assessed in the concentration range of 0.0012 to 200 µg ml-1. Since 
nanoparticles themselves possess absorption characteristics, a background control plate 
was set up, in which varying concentrations of AgNPs were plated with the respective 
media and the absorbance was used for removal of AgNP background absorbance by 
reducing the results of their corresponding test replicates in sample antibacterial and 
antifungal assay plates.  
3.3.7.3  Antibacterial assay  
Bacterial susceptibility was determined according to the broth microdilution method 
(Schwalbe, et al., 2007). The bacterial strains were freshly inoculated into 50 ml of MH 
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broth. The cultures were incubated overnight at 37°C in an Infors HT Multitron 
environmental shaker (United Scientific, South Africa) at 150 rpm. To obtain working 
suspensions with optical densities in the range of 0.08-0.10 which conform to 
McFarland’s constant, the absorbance of overnight starter cultures was determined 
spectrophotometrically at a wavelength of 625 nm. The absorbance of experimental 
suspensions were adjusted by dilution with MH broth. Aliquots (100 µl) of experimental 
cultures were dispensed into microtitre plates containing 100 µl samples (AgNPs; leaf 
tissue and antibiotics) as prepared in the previous section and uninhibited growth control 
wells. The microtitre plate cultures were incubated aerobically for 16-18 h at 37°C. 
Subsequently, 40 µl of freshly prepared iodonitrotetrazolium chloride (2-(4-iodophenyl)-
3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride, INT, 200 µg ml-1) solution was 
added to all wells and the plates incubated in the dark for 45 minutes at 37°C. The INT 
reagent, initially colourless, was reduced to a red product following incubation. This 
reduction was the result of persistent bacterial growth, whilst no colour change denoted 
the inhibition or lack of bacterial growth. The absorbance was determined at 630 nm using 
a multimodal plate reader (Biotek Synergy HT, USA) with Gen 5 software (Biotek 
Synergy HT, USA Ver 2.01.14). The experimental design included two biological 
replicates and in each instance three technical replicates per sample were used. 
3.3.7.4  Antifungal assay  
The antifungal activity of AgNPs was determined using the broth microdilution method 
as prescribed by the NCCLS guidelines (NCCLS, 2002). Strains were inoculated into 
freshly prepared SD broth (50 ml) and grown aerobically overnight at 30°C in an Infors 
HT Multitron environmental shaker (United Scientific, South Africa) at 150 rpm. The 
cells were harvested by centrifugation at 4°C for 5 minutes at 4000 rpm and thereafter re-
suspended in 1% saline (10 ml). The absorbance of resuspended starter cultures was 
determined spectrophotometrically at 600 nm. To conform to McFarland’s standards, the 
cells were diluted using SD broth to achieve optical densities in the range of 0.08-0.10. 
Once achieved, the working suspension was diluted (1:20) in RPMI 1640 medium (with 
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L-glutamine, without bicarbonate and phenol red, Biochrom, Berlin). The working 
suspension was further diluted (1:50) with RPMI 1640 to obtain the final test inoculum 
concentration of 1-5 x 103 CFU ml-1. Aliquots (100 µl) of inoculum were added to all 
wells of the test microtitre plates except the blank/negative control wells and nanoparticle 
control plate. The plates were incubated aerobically at 30°C for 16-20 h. After incubation, 
20 µl of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H terazolium salt (MTS, Promega Corporation, Madison, USA) was added to each well 
and incubated in the dark at 30°C for 4 h. Thereafter the absorbance was determined at 
490 nm. The experimental design included two biological replicates and in each instance 
three technical replicates per sample were used. 
3.3.8  Data analysis  
All data were statistically analysed using SPSS version 21. All percentage data obtained 
from the biological assays were arcsine transformed and analysed for normality (p>0.05) 
using a Kolmogorov-Smirnov test. Parametric data (which in some cases the consequence 
of transformation) were subjected to an analysis of variance (ANOVA). Differences were 
considered significant at the 0.05 level and where possible, means were separated by a 
Tukey post-hoc test. Nanoparticle yield and size were analysed for normality as above 
and subjected to an Independent sample t-test.  
 
3.4  RESULTS  
3.4.1  Confirmation of AgNP synthesis  
A primary indication of AgNP formation is represented by a reaction solution colour 
change to dark brown (Veerasamy, et al., 2011). Addition of AgNO3 to FD and F M. 
oleifera leaf extract samples produced an instantaneous colour change from an initial, 
yellow solution for both FD and F samples (Fig. 3.1a & Fig. 3.1b), to dark brown 
solutions (Fig. 3.1c & Fig. 3.1d) within 1 h of reaction time.  
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Figure 3.1 Colour change of reaction solutions containing FD (a & c) and F (b & d) leaf extract 
samples with AgNO3 at 0 h and 1 h.  
 
3.4.2  Characterisation of AgNPs 
3.4.2.1  UV-Vis Spectral analysis 
The UV-Vis spectral profiles using AgNPs prepared from both leaf sample types 
displayed absorbance peaks at 440 nm and 450 nm which is characteristic of AgNP 
containing solutions (Logeswari, et al., 2012). The absence of an absorbance peak at these 
wavelengths for the control solution containing AgNO3 and distilled water confirmed the 
involvement of leaf compounds in the reduction of Ag+ and subsequent generation of 
AgNPs (Fig. 3.2). 
 
Figure 3.2 UV-Vis spectral profiles of AgNP containing solutions synthesised from FD and F 
M. oleifera leaf extract samples and control solution after 1 h of reaction. 
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3.4.2.2  Yield analysis 
Nanoparticle yield for AgNPs prepared from FD leaf samples (0.91±0.4 mg AgNPs/g leaf 
tissue dry mass) was statistically comparable (p˃0.05) to that obtained for AgNPs 
prepared from F samples (0.81±0.2 mg AgNPs/g leaf tissue dry mass) (Fig. 3.3).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 AgNP yield from FD and F M. oleifera leaf extract samples (mg AgNPs/g leaf tissue 
dry mass). Values represent mean±SD (n=4). p>0.05 when yield was compared between FD and 
F leaf extract samples (t-test). 
 
3.4.2.3  SEM and EDX analysis 
SEM analysis of purified nanoparticle solutions revealed that the particles were roughly 
spherical in shape (Fig. 3.4a & Fig. 3.4c). Additionally, the particles were observed to be 
highly agglomerated, possibly an artefact of the centrifugation and subsequent drying 
required to prepare AgNP samples for SEM analysis. EDX analysis demonstrated a 
strongly well defined silver signal along with weak carbon, oxygen and nitrogen peaks, 
with the latter weaker signals probably representing surface biomolecule capping 
structures originating from the leaf extracts (Fig. 3.4b & Fig. 3.4d). 
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Figure 3.4 SEM images and EDX spectra of AgNPs prepared from FD (a and b) and F (c and 
d) leaf extract samples, respectively. 
 
3.4.2.4  TEM  
TEM was used to characterise the morphology of AgNPs in terms of their shape, size and 
size class distribution. Sample preparation for TEM analysis did not require physical 
dehydration stated for SEM studies above. As mentioned previously, the latter procedure 
may promote agglomeration thereby limiting concise characterisation. TEM analysis 
clearly showed that the particles are spherical in shape and appear well dispersed (Fig. 
3.5a & Fig. 3.5b). Comparing the morphological characterisation techniques used in this 
study, it seems that TEM analysis strongly suggests that compounds originating from leaf 
extracts exhibit the dual role of reducing Ag+ as well as stabilising synthesised particles. 
Additionally TEM analysis revealed the particles possess narrow size distributions with 
average sizes of 11±4.3 nm and 9±4.2 nm for FD and F AgNPs, respectively. (Fig. 3.6a 
& Fig. 3.6b). p>0.05 when sizes were compared between FD and F leaf extract samples 
(t-test). 
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Figure 3.5 TEM images of AgNPs produced from (a) FD and (b) F leaf samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6a Size distribution of AgNPs synthesised from FD leaf samples of M. oleifera. (n=100, 
p˃0.05 when compared with AgNPs prepared from F samples, t-test). 
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Figure 3.6b Size distribution of AgNPs synthesised from F leaf samples of M. oleifera. (n=100, 
p˃0.05, when compared with AgNPs prepared from FD samples, t-test). 
 
3.4.2.5  FTIR 
FTIR analysis of FD and F leaf material and the corresponding AgNPs (Fig. 3.7) revealed 
that similar or identical functional groups in both leaf sample types were responsible for 
binding and reducing Ag+. Functional groups corresponding to absorbance peaks in the 
range of 3000-3300; 2800-3000; 1626; 1400-1550; 1380-1403 and 1000-1100 cm-1 were 
observed. These peaks are known to be associated with stretching vibrations of hydroxyl 
groups in alcohols or phenolic compounds (Chandran, et al., 2006); CH2 and CH3 
functional groups; C=C groups of aromatic compounds or C=O groups of carboxylic 
acids (Shankar, et al., 2004); Amide I (CONH2) and Amide II (CONH) groups (Awwad, 
et al., 2013); geminal methyls; ether linkages and C-O or C-O-C functional groups, 
respectively (Shankar, et al., 2004). In contrast these peaks, were either absent or 
displayed drastically reduced intensities in the corresponding AgNP spectra. This seems 
to suggest that functional groups in this region are involved in the reduction and 
stabilisation of the AgNPs by their subsequent oxidation. Additionally, ether linkages, C-
O and C-O-C functional groups are thought to be groups of flavones, terpenoids and 
polysaccharides, in the leaf biomass that are adsorbed on the metal surface (Shankar, et 
al., 2004). 
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Figure 3.7 (a) FTIR spectrum of FD leaf sample (plant) and AgNPs derived from FD leaf 
sample; (b) FTIR spectrum of F leaf sample (plant) and AgNPs derived from F leaf sample. 
 
3.4.5  Bioactivity of AgNPs 
Bioactivity against microbes in this study was determined in terms of the minimal 
inhibitory concentration (MIC) i.e. the lowest concentration of an AgNP solution to 
inhibit 80 to ˃ 80% growth of a microorganism was considered as a positive inhibition 
result.  
3.4.5.1  Antibacterial studies 
The AgNPs synthesised from both leaf sample types displayed inhibition of Gram-
negative and Gram-positive-bacteria (Table 3.1). Solutions of AgNPs from both leaf 
preparations at a concentration of 25 µg ml-1 inhibited the growth of K. pneumoniae, P. 
aeruginosa and S. aureus strains. Interestingly, a two-fold decrease in concentration (12.5 
µg ml-1) of both AgNP preparations was observed to inhibit the growth of E coli, and E. 
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faecalis. Importantly, no significant differences were noted for the antibacterial activities 
of AgNP preparations within each bacterial strain (p˃0.05). Both Moringa leaf extract 
samples did not display inhibitory activities throughout the concentration range (200-6.25 
µg ml-1) evaluated in this study (data not shown). Commercially available antibiotics 
namely: neomycin, ciprofloxacin hydrochloride and gentamicin displayed MIC’s ranging 
from 0.39 to 200 µg ml-1 and in certain instances displayed no inhibition. Attractively, 
the data seems to suggest that AgNPs prepared in this study are not only more effective 
at lower concentrations but also display a broader susceptible bacterial spectrum range. It 
is noteworthy that E. faecalis was insensitive to three commercial antibiotics but was 
susceptible to the AgNPs prepared from both leaf extracts.  
 
Table 3. 1 MIC80 of AgNPs synthesised from M. oleifera leaf extract samples and commercial 
antibiotics against bacterial strains 
 MIC (µg ml-1) 
Organism AgNPs 
synthesised 
from FD 
tissue 
AgNPs 
synthesised 
from F 
tissue 
Neomycin Ciprofloxacin 
hydrochloride 
Gentamicin 
E. coli 12.5±0.01 12.5±0.01 6.25±0.04 0.39±0.01 1.56±0.07 
E. faecalis 12.5±0.01 12.5±0.00 NI* NI* NI* 
K. pneumoniae 25±0.01 25±0.02 25±0.04 25±0.02 6.25±0.07 
P. aeruginosa 25±0.01 25±0.01 NI* 1.56±0.05 200±0.06 
S. aureus 25±0.03 25±0.04 NI* 1.56±0.09 NI* 
Data are reported as the mean ± SD. (p˃0.05, for FD and F AgNP preparations within each microorganism 
tested, ANOVA) NI = No inhibition. *Commercial antibiotics showed no inhibition in terms of effecting 80 
% kill at their evaluated concentrations. 
 
 
3.4.5.2  Antifungal studies 
Three Candida reference strains were employed to evaluate the antifungal potency of the 
AgNP preparations (Table 3.2). It was observed that both AgNP preparations displayed 
similar inhibitory activities (p˃0.05) for each fungal strain. A concentration of 6.25 µg 
ml-1 AgNPs inhibited the growth all fungal strains whilst the leaf extract samples did not 
display inhibition (data not shown). The pharmaceutical bioactive amphotericin B 
displayed a MIC of 0.02 µg ml-1 across all evaluated fungal strains.  
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Table 3. 2 MIC80 of AgNPs synthesised from M. oleifera leaf extract samples and a commercial 
antifungal preparation against fungal strains 
 MIC ( µg ml-1) 
Organism AgNPs synthesised 
from FD tissue 
AgNPs synthesised 
from F tissue 
Amphotericin B 
C. albicans 6.25±0.03 6.25±0.02 0.02±0.00 
C. krusei 6.25±0.02 6.25±0.02 0.02±0.00 
C. parapsilosis 6.25±0.02 6.25±0.01 0.02±0.00 
Data are reported as the mean ± SD. (p˃0.05, for FD and F AgNP preparations within each microorganism 
tested, ANOVA). 
 
3.5  DISCUSSION  
Given the wide ranging of applications touted for AgNPs in recent years, many 
researchers have focused on the development of modified or novel synthetic strategies for 
AgNPs as opposed to the use of conventional methods which are strongly associated with 
toxic environmental footprints (Patra and Baek, 2014). This study reports on the 
antimicrobial activities of AgNPs prepared from leaf extract samples of the medicinal tree 
species, M. oleifera by a clean green cost effective synthetic method.  
Up until now, green synthesis of AgNPs from leaf extract samples at room temperature 
were shown to yield AgNPs at relatively slow rates. For instance, complete bioreduction 
of Ag+ from Aloe vera and Iresine herbstii leaf extracts occurred at 24 h and 168 h, 
respectively (Chandran, et al., 2006, Dipankar and Murugan, 2012). The aforementioned 
disadvantage of certain green synthetic routes requires optimisation to be a viable 
alternative to the use of conventional chemical methods for AgNP synthesis. With this in 
mind, several researchers have implemented physical parameters such as heat to drive 
green nanoparticle formation. Prasad and Elumalai (2011) reported rapid synthesis (10 
minutes) of AgNPs from M. oleifera leaf powder at a reaction temperature range of 60-
80°C (Prasad and Elumalai, 2011). In a separate study, Veerasamy et., al (2011) reported 
the temperature profile (37-90°C) of AgNP synthesis from mangosteen leaf extracts. In 
their study, maximum AgNP formation occurred after 1 h at 75°C. In addition, the group 
also reported that incubation time is an important consideration in AgNP synthesis since 
extended exposure to heat promotes agglomeration of AgNPs to yield undesirable 
particles of larger size (Veerasamy, et al., 2011). As suggested by previous studies, 
sunlight irradiation, a freely available bio-energy resource, was used to drive nanoparticle 
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formation (Annadhasan, et al., 2012, Karimi Zarchi, et al., 2011, Rastogi and 
Arunachalam, 2011). Reduction of Ag+ by M. oleifera leaf extracts occurred 
instantaneously in the presence of direct sunlight and complete reduction was observed 
after 1 h. This was indicated by colour change of the reaction solutions to dark brown as 
it has previously been reported that AgNPs display a brown colour in aqueous solution 
due to their surface plasmon phenomenon (Veerasamy, et al., 2011). Additionally, this 
phenomenon also facilitates their detection in the UV-region and hence, provided a 
further indication of their formation (Kim, et al., 2007). Previous studies on sunlight 
driven AgNP synthesis using Allium sativum (garlic extract); Andrachnea chordifolia 
ethanol leaf extract and the sodium salt of N-cholyl amino acids revealed that sunlight 
rapidly enhanced nanoparticle formation with reduction times observed in the range of 5-
15 minutes (Annadhasan, et al., 2012, Karimi Zarchi, et al., 2011, Rastogi and 
Arunachalam, 2011). This seems to suggest that the time required for nanoparticle 
formation varies according to the nature of reducing agent. However, considering the 
reducing times reported for the use of sunlight irradiation as a primary energy source, this 
technology constitutes a promising alternative to the use of non-renewable energy sources 
for AgNP production. 
Yield analysis indicated no significant differences between AgNPs prepared from FD or 
F leaf sample types. Although, it has previously been reported that the dehydration of 
plant material increases the availability of phytocompounds and would therefore increase 
the bioactivity of the plant material (in terms of their reducing ability) (Larson, 1988). To 
date, AgNP recovery from leaf samples is relatively unreported. However, AgNPs 
produced in this study are comparable to previously derived AgNPs prepared from 
various organ extracts of Amaranthus dubius (Sigamoney, et al., 2016). 
Microscopic analysis (SEM) provided an inconclusive indication that AgNPs were 
spherically shaped. In addition, the particles appeared to be highly agglomerated, possibly 
owing to the physical dehydration exerted during the SEM sample preparation procedure 
(Sadeghi and Gholamhoseinpoor, 2015, Sigamoney, et al., 2016). In contrast, TEM 
analysis of aqueous AgNP samples provided unequivocal evidence that the prepared 
AgNPs were spherical in shape. Furthermore, the particles were observed to be stable and 
dispersed, even within aggregates. This finding is in accordance with previously derived 
AgNPs from M. oleifera leaf extracts (Prasad and Elumalai, 2011, Sathyavathi, et al., 
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2011) suggesting that the leaf extract of M. oleifera presents a dual functionality of 
reducing Ag+ and subsequently stabilising nascent AgNPs. Interestingly, a previous study 
on the influence of AgNP shape on bioactivity suggested that spherically shaped AgNPs 
display superior antimicrobial activities when compared to rod shaped AgNPs (Pal, et al., 
2007). 
Characteristically, nanoparticles are small in size (1-100 nm) and harbor a large surface 
area that constitutes their reactivity (Christian, et al., 2008). In recent years however, 
studies have suggested that the bioactivity of AgNPs occur in a size-dependent manner 
with smaller particles exerting better bioactivities than larger particles (Jeong, et al., 2014, 
Martinez-Castanon, et al., 2008). Size class distribution studies of the AgNPs prepared in 
this study indicate that the particles had narrow size distributions with average diameters 
of 9±4.2 nm and 11±4.3 nm for AgNPs prepared from the respective F and FD leaf extract 
samples. No significant differences were noted for AgNP preparations in terms of their 
size. Previously synthesised AgNPs from the leaf extracts of Ziziphora tenuior and 
Mimusops elengi at room temperature were found to range in size of 20-83 nm (Prakash, 
et al., 2013, Sadeghi and Gholamhoseinpoor, 2015). The introduction of heat in AgNP 
synthesis has been reported to significantly decrease the size of synthesised AgNPs 
(Veerasamy, et al., 2011). However, AgNPs synthesised from M. oleifera leaf powder 
extract in a heat driven process produced particles with an average diameter of 57 nm 
(Prasad and Elumalai, 2011). It can be suggested that incubation at room temperature or 
heat strongly influences the size of generated nanoparticles according to the nature of 
reducing agent. Attractively, the use of sunlight in the aforementioned AgNP synthesis 
from A. sativum and A. chordifolia extracts were reportedly 7.3 nm and 3.4 nm, 
respectively. These findings and the data reported in this study strongly favour the use of 
sunlight for the production of AgNPs with small sizes. 
EDX analysis revealed that in addition to silver, oxygen; carbon and nitrogen were also 
present on the nanoparticle surface. Similar results were reported by Song and Kim (2009) 
and believed to originate from biomolecule capping structures (Song and Kim, 2009). 
Importantly, AgNPs with oxidised surfaces have been reported to induce the formation 
of “holes” on the surface of bacteria (Smetana, et al., 2008), which suggests that the 
presence of oxygen on the surface of the nanoparticles prepared here may enhance their 
bactericidal activities. 
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FTIR analysis suggest the presence of phenolic compounds, flavones, terpenoids and 
polysaccharides in the leaf biomass as potential Ag+ capping agents. Interestingly, M. 
oleifera leaves are known to be a rich source of the antioxidant phenolic compounds: 
quercetin and kaempferol (Siddhuraju and Becker, 2003). In particular, quercetin 
belonging to the flavonoid group of phenolic compounds has previously been shown to 
possess strong chelating ability (Makarov, et al., 2014). This tentatively suggests that the 
reducing of Ag+ by quercetin may potentially reduce the cytotoxic effects of AgNPs 
produced in this study.  
This is the first report on characterisation of M. oleifera leaf derived AgNPs using sunlight 
in terms of their MIC bioactivities. Antimicrobial screening of AgNPs revealed strong 
inhibition of Gram-negative and Gram-positive bacteria as well as various fungal species, 
irrespective of whether they were derived from F or FD leaf sample material (p˃0.05). 
More specifically, MIC values were recorded in the range 12.5-25 µg ml-1 for bacterial 
strains and 6.25 µg ml-1 for fungal strains.  
The effective inhibition of both Gram-negative and Gram-positive bacteria by AgNPs 
derived from M. oleifera leaf extracts is of great significance as it demonstrates their 
broad-spectrum antibacterial activity. It also indicates that the mode of action is not 
affected by the difference in membrane stabilities of the bacteria since Gram-positive 
bacteria contain a thick peptidoglycan layer whilst Gram-negative bacteria possess a rigid 
outer membrane structure composed of lipids and lipoproteins. Contrasting results were 
observed in a similar study where AgNPs (5-35 µg ml-1) synthesised from reducing agents 
such as D-glucose and hydrazine, displayed effective activity towards Gram-negative 
bacteria but minimal activity against Gram-positive bacteria (Shrivastava, et al., 2007). 
Additionally, in the previously mentioned study on AgNPs derived from M. oleifera leaf 
powder, no activity against K. pneumoniae was noted. This might be due to the fact that 
AgNPs in the present study are ± 6 times smaller than those in the previous study (Prasad 
and Elumalai, 2011). It is worth mentioning that E. faecalis displayed resistance to all 
three commercial antibiotics but was susceptible to both AgNPs prepared in this study. 
This is significant since this bacterium has previously been reported for its intrinsic 
resistance and further acquisition of resistance genes leading to the emergence of E. 
faecalis as a nosocomial pathogen that is a refractory to most therapeutic agents (Paulsen, 
et al., 2003). In addition, the conjugative transfer of high levels of resistance genes from 
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E. faecalis to S. aureus has been long established and may probably explain the increased 
incidence of S. aureus resistance to both neomycin and gentamicin observed in this study 
(Noble, et al., 1992).  
Both AgNP preparations displayed good antimicrobial activities against all fungal test 
strains. These findings are contradictory to what has been suggested by Nabikhan et al., 
(2010) that AgNPs are better antibacterial agents rather than antifungal agents. This 
notion was supported by the finding that AgNPs are able to freely adhere to and penetrate 
bacterial cells, whilst they are unable to enter fungal cells at low concentrations 
(Nabikhan, et al., 2010). The AgNPs produced in this study show no alteration in 
bioactivity between bacterial and fungal organisms, suggesting that their mode of action 
remains unaffected by the difference in the cell wall structures of these organisms. 
Importantly, AgNPs produced in this study display bioactivities at concentration doses 
that are generally associated with limited or no cytotoxic potential (Dipankar and 
Murugan, 2012) and therefore provide promising broad-spectrum antimicrobial 
alternatives to orthodox antibiotics which may provide much needed relief to the health 
care delivery system. 
 
3.6  CONCLUSION 
Development of greener alternatives for AgNP synthesis has emerged as an important 
branch of nanotechnology due to the urgent need for novel, bio-compatible antimicrobial 
agents. In the present study, AgNPs with desirable physical attributes were produced 
equally well from FD and F leaf extract samples of M. oleifera by the use of sunlight 
irradiation as an alternative energy source. The produced AgNPs were comparable in 
terms of their yield, morphology and bioactivities and seemingly suggests that freeze-
drying of the leaf material may be useful in their preservation for future nanoparticle 
synthesis. Importantly, AgNPs displayed a broad-spectrum antimicrobial susceptibility 
range and therefore represent as promising antimicrobial agents with potential 
applications in pharmaceutical industries for controlling pathogenic microorganisms. 
However, more research needs to be done on characterising the capping agents that may 
harbor potential antioxidant activities. Issues of safety and toxicity around their use for 
treatment in humans also needs to be considered but this nevertheless presents a simple, 
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economical and environmentally friendly method for the rapid synthesis of bioactive 
AgNPs from the leaves of one of the most widely investigated and used medicinal tree 
species, M. oleifera.  
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4.1  ABSTRACT 
The development and adaptation of green synthetic methods for silver nanoparticle 
(AgNP) synthesis has flourished into a widely researched area of nanotechnology. 
Particularly, in the development of AgNPs for application as antimicrobial agents. The 
current study encompasses the synthesis, characterisation and antimicrobial evaluation of 
AgNPs derived from the cell free supernatant (CFS) of the bacteriocin producer 
Pediococcus acidilactici and its comparison to AgNPs derived from CFS of a non-
bacteriocin producing Bacillus subtilis strain. Interestingly, sunlight irradiation, a 
relatively unexplored primary energy source was able to photo-catalyse nanoparticle 
formation completely within 1 hour of exposure as observed by reaction color change and 
UV-Vis spectral analysis. Transmission electron microscopy (TEM) confirmed that both 
AgNP preparations were consistent in their spherical shape, with average diameters of 16 
nm and 12 nm for AgNPs derived from CFSs of P. acidilactici and B. subtilis, 
respectively. Fourier transform infrared spectroscopy (FTIR) and Energy dispersive X-
ray (EDX) analysis identified the presence functional groups on the surface of both 
AgNPs which may originate from protein molecules. This seemingly suggests that AgNP 
formation from both extracts occurred via the oxidation of proteins by Ag+. Bioactivity 
screening revealed that AgNPs were generally comparable and exhibited broad-spectrum 
antimicrobial activity against both bacterial and fungal strains. Importantly, our findings 
suggest that AgNPs derived from P. acidilactici and B. subtilis extracts exhibit potential 
for application as broad-spectrum antimicrobial agents. Moreover, this approach seems 
to be cost-effective, eco-friendly and can be easily up-scaled for large production. 
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4.2  INTRODUCTION 
The increase in antimicrobial resistance to commercial antibiotics is of tremendous 
concern that threatens the well-being of global populations. In fact, the problem has 
escalated to an extent that a post-antibiotic era, one in which fatalities could potentially 
arise from common infections and minor injuries, is a scary reality for the 21st century 
(World Health Organisation, 2014).  
Microbial development of drug resistance is a complex phenomenon driven by various 
intricate factors, of which the foremost is through the improper use of antibiotics (World 
Health Organisation, 2001). This is due to the inherent ability of microbes to rapidly 
develop resistance mechanisms when a subset of the microbial population survives 
exposure to the drug (Seil and Webster, 2012). In addition, microbial exogenous gene 
transfer mechanisms further accelerate the spread of resistance genes between 
microorganisms (Tomasz, 2006). Although the development of novel antimicrobial 
agents is a daunting and economically draining exercise, nevertheless an urgent 
uncovering of such antimicrobial agents is becoming increasingly unavoidable. (Ventola, 
2015).  
The antimicrobial effects of silver salts although not well understood has been in use since 
ancient times (Kim, et al., 2007). However with the discovery of the antibiotic penicillin, 
the use of silver salts and other antimicrobial preparations became obsolete (Alexander, 
2009). As mentioned above, with the increasing prevalence of microbial drug-resistance, 
the application of this metal using modern technologies to generate its nano-particulate 
form has resurfaced as a promising antimicrobial candidate (Kim, et al., 2007, Rai, et al., 
2009). Currently, a host of methodologies for AgNP synthesis comprises various physical 
and chemical strategies (El-Nour, et al., 2010, Iravani, et al., 2014). However, the 
experimental nature of these methods (i.e. the use of toxic chemicals and/or adverse 
reaction conditions) is much cause for debate which limits the application of produced 
nanoparticles (Thakkar, et al., 2010). In recent years, ongoing advancements in 
nanotechnology have led to the development of greener alternatives for AgNP synthesis 
wherein environmentally inert capping agents are utilised in the reduction of metal ions 
(Dauthal and Mukhopadhyay, 2016, Rajput, et al., 2016). 
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Developing biological approaches for AgNP synthesis is an ongoing branch of 
nanotechnology and researchers are currently focused on identifying new reducing or 
capping agents for production of AgNPs with superior bioactivities (Hazarika, et al., 
2016). To this end, a variety of capping substrates from diverse biological sources have 
been explored for AgNP synthesis including plants, algae, fungi, yeast, bacteria, 
mammalian cells and viruses (Makarov, et al., 2014, Pantidos and Horsfall, 2014, 
Thakkar, et al., 2010). Incidentally, laboratory based nanoparticle synthesis from extracts 
of a biological resource is favored over their biosynthesis in living organisms due to 
several distinct advantages including: short reaction times; ease of handling extracts 
compared to whole organisms; high yield of nanoparticles and importantly, the lack of 
costly downstream processing required to obtain to the produced particles (Das, et al., 
2014, Gannimani, et al., 2014, Liu, et al., 2005).  
The use of bacterial extracts as reducing agents in the production of AgNPs have been 
reported with optimised reaction times that are comparable to chemical approaches for 
AgNP synthesis (Shahverdi, et al., 2007). Furthermore, the abundance and rapid growth 
rate of bacteria coupled to the possibility of their genetic modification for increased 
production of a well-defined capping substrate marks these organisms as promising 
candidates for AgNP production (Pantidos and Horsfall, 2014). In this regard, the present 
study evaluates the bio efficacies of AgNPs generated from an antimicrobial peptide 
producing bacterium to their counterparts generated from a non-producing strain.  
Pediococcus acidilactici PAC1.0. is a Gram-positive homofermentive microbe belonging 
to the family Lactobacillaceae and is renowned for its inhibitory effects against the 
pathogenic bacterium, Listeria monocytogenes. This inhibition attributed to the plasmid-
encoded production of the bacteriocin pediocin PA-1, a small (<10 kDa) heat-stable 
peptide produced extracellularly. More concisely, the current study was conceptualised 
on the basis that nanoparticle formation using capping structures present in spent culture 
supernatants of P. acidilactici may potentially produce AgNPs with higher antimicrobial 
efficacies as those compared to AgNPs from a non-bacteriocin producing strain (Marugg, 
et al., 1992).  
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To date, the use of sunlight irradiation, a relatively new source of energy has been 
reported to drive AgNP formation using plant extracts and to a lesser extent, bacterial 
extracts (Karimi Zarchi, et al., 2011, Rastogi and Arunachalam, 2011, Wei, et al., 2012). 
In this study, the use of this energy source to drive nanoparticle formation from bacterial 
extracts was explored and the resulting AgNPs characterised in terms of their morphology 
and bioactivity. The data presented in this study seemingly suggest that AgNPs produced 
from both bacteriocin containing and non-containing extracts are interesting candidates 
for further development towards controlling drug-resistant microbial infections. 
 
4.3  MATERIALS AND METHODS 
All chemicals, solvents and media used in this study were of analytical grade and 
purchased from Merck (Pty) Ltd, South Africa, unless stated otherwise. Antibiotics were 
purchased from Sigma Aldrich, Germany. 
4.3.1  Strains  
The bacteriocin producing strain P. acidilactici PAC1.0.was kindly provided Professor 
L.M.T Dicks from the Department of Microbiology, Stellenbosch University. A non-
producing Bacillus subtilis strain was obtained from the Department of Biochemistry, 
University of Kwa-Zulu Natal. Strains used in bioactivity assays were from the American 
Type Culture Collection (ATCC): Staphylococcus aureus (43300); Enterococcus faecalis 
(5129) (Gram-positive); Escherichia coli (35218); Pseudomonas aeruginosa (27853); 
Klebsiella pneumoniae (700603) (Gram-negative); Candida albicans (10231); Candida 
krusei (6258) and Candida parapsilosis (22019). 
4.3.2  Preparation of CFS  
Preparation of CFSs was conducted by the method of Gonzalez and Kunka (1987). 
Briefly, 100 ml of de Man, Rogosa and Sharpe (MRS) broth was individually inoculated 
(1%) with overnight cultures of P. acidilactici and B. subtilis grown in the same medium. 
Cultures were incubated statically at 35°C for 24 h. Thereafter, the pH of the cultures were 
adjusted to pH 6.0 and the cells were removed by centrifugation (Eppendorf centrifuge 
5810 R, Germany) at 4000 rpm for 10 min. The CFSs were filter sterilised (0.45 µm 
filters, (GVS, USA) and subsequently stored at 4°C (Gonzalez and Kunka, 1987). 
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4.3.3   Assay for bacteriocin production 
The spot on lawn method was used to confirm bacteriocin production by P. acidilactici 
and non-production by B. subtilis (Pucci, et al., 1988). Mueller Hinton (MH) plates were 
overlaid with room temperature equilibrated soft agar (0.75% w/v) that was seeded with 
test culture cells (≈ 106 cells ml-1). An aliquot (10 µl) of CFS was spotted onto overlaid 
MH plates. Inoculated plates were incubated at 37°C for 18 h. A clear zone of inhibition 
around spotted inoculum areas indicated a positive result for the presence of bacteriocins 
in the CFS. 
4.3.4   Protein determination of CFSs 
The total protein content of CFSs was determined using the microplate procedure of the 
BCA Protein Assay (Pierce 23225, Thermo Scientific, USA) according to the 
manufacturer’s specifications. Distilled water was used as a solvent to make up dilutions 
of the CFSs. Absorbance of test wells at 562 nm were determined using a multimodal 
plate reader (Biotek Synergy HT, USA) with Gen 5 software (Biotek Synergy HT, USA 
Ver 2.01.14). Subsequently, the protein concentrations of both CFSs were equilibrated to 
contain a final protein content of 50 mg ml-1. 
4.3.5  Synthesis of AgNPs  
Preparation of reaction solutions for AgNP synthesis was adapted from Shahverdi et al., 
(2007). An aliquot (5 ml) of P. acidilactici CFS extract was added to 50 ml of aqueous 
1x10-3 M silver nitrate (AgNO3) contained in a 100 ml clear glass reaction vessel. The 
aforementioned reaction was also performed using 5 ml of B. subtilis CFS extract. To 
drive formation of AgNPs, the reaction mixtures were exposed to direct sunlight. Colour 
change of the reaction mixtures were monitored to determine nanoparticle formation 
which is indicated by a dark brown colour. Once colour intensities of the solutions 
reached a maximum, the vessels were removed from sunlight and stored in darkness at 
room temperature to prevent agglomeration of the nanoparticles. A 50 ml aliquot of 
AgNO3 containing 5 ml distilled water was processed as described above and used as a 
negative control (Shahverdi, et al., 2007). 
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4.3.6   UV-Vis Spectral analysis 
Preliminary characterisation of synthesised AgNPs was carried out by UV-Vis spectral 
analysis. Nanoparticle solutions were first diluted 1:2 with distilled water (200 μl of 
nanoparticle sample and 400 μl of distilled water). Thereafter the absorbance of diluted 
AgNPs and AgNO3 was scanned from 190 to 800 nm using a UV-Vis spectrophotometer 
(Specord 210 Analytikjena, Germany). Distilled water was used as a blank to adjust the 
baseline.  
4.3.7  Purification and concentration of AgNPs 
The purification and concentration of AgNPs from the final reaction mixture was adopted 
from the method available in literature, (Dipankar and Murugan, 2012). Reaction 
mixtures were split into two equal parts and transferred to pre-weighed sterile 50 ml 
centrifuge tubes (United scientific, South Africa). The preparations were then centrifuged 
at 4000 rpm for 2 h (Eppendorf centrifuge 5810 R, Germany), at 4°C. Supernatants were 
discarded and the pellet washed in 10 ml of sterile distilled water before centrifugation 
for 1 h as per the conditions described above. This wash step was repeated twice to 
remove water soluble biomolecules such as proteins and cellular metabolites. One half of 
each replicate was then dried in an oven at 37°C for 24 h to determine the dry mass of the 
AgNPs (difference between mass of tube + nanoparticles, and mass of tube), whilst the 
other half of each replicate was reconstituted in 1 ml of distilled water. The mass of each 
dried pellet was applied as the equivalent mass of its corresponding reconstituted pellet 
since each replicate was equally split. Thus, the concentration of AgNPs was determined 
on a mg/ml basis. Dry AgNP samples were kept at room temperature whilst reconstituted 
samples were stored at 4°C prior to use. 
4.3.8   Characterisation and analysis of AgNPs  
Characterisation techniques were adopted from Gannimani et al., (2014). Dry AgNP 
samples were used for Scanning electron microscopy (SEM), Energy dispersive x-ray 
(EDX) and Fourier transform infrared spectroscopy (FTIR) analysis whereas 
reconstituted samples were used in Transmission electron microscopy (TEM) analysis 
(Gannimani, et al., 2014).  
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4.3.8.1   SEM and EDX analysis  
Morphological characteristics of AgNPs were determined using SEM (FEGSEM Zeiss 
Ultraplus). Purified nanoparticle mass was placed on a carbon tape stuck to a clean 
aluminium stub. Samples were then coated with gold and observed at 10000 X 
magnification followed by EDX analysis at 20 kV to determine the elemental composition 
of the particles. AZTEC software (Oxford Instruments NanoAnalysis, Ver 1.2), was used 
for the analysis.  
4.3.8.2  TEM 
Transmission electron microscopy was employed to determine concise nanoparticle 
characteristics such as shape, size and size class distribution. Reconstituted, pure AgNP 
samples were first sonicated to maintain an even distribution of the nanoparticles in 
solution prior to TEM analysis. Samples (n=3) were prepared by placing a small amount 
of nanoparticle solution onto a carbon-coated copper grid which was then dried under a 
lamp. Sample images were obtained using a JEOL TEM (1010) at an accelerating voltage 
of 100 kV. The sizes of the nanoparticles and data analysis of the sizes was accomplished 
using ITEM (Soft imaging system, Germany Ver 5.0). 
4.3.8.3  FTIR  
The purified dry mass of AgNPs were subjected to FTIR analysis (Perkin Elmer Spectrum 
One, USA) to identify biological functional groups capping the surface of the 
nanoparticles. The respective spectra were obtained using Spectrum Analysis Software.  
4.3.9  Biological Assays  
4.3.9.1  Antimicrobial agents 
Reconstituted AgNPs derived from bacterial CFSs were sonicated to maintain an even 
distribution of the nanoparticles in solution prior to use in the bioassays. Testing was 
conducted in 96-well flat-bottom microtitre plates (Greiner bio-one, Germany) using final 
AgNP concentrations ranging from 6.25 to 200 µg ml-1. The first row (row A) of the 
plates were reserved for blank/negative and uninhibited growth controls as the wells were 
filled with media only (MH for antibacterial testing and Sabouraud-2% dextrose (SD) for 
antifungal testing, respectively) Aliquots of 100 µl of twofold serial dilutions of AgNPs 
(2 x final concentrations) were added for analysis. The commercially available 
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antibiotics: neomycin; gentamicin; ciprofloxacin hydrochloride (bacteria) and 
amphotericin B (fungi) were used as positive antibiotic controls and assessed in the 
concentration range of 0.0012 to 200 µg ml-1. Since nanoparticles themselves possess 
absorption characteristics, a background control plate was set up, in which varying 
concentrations of AgNPs were plated with the respective media. The absorbance was used 
for removal of AgNP background absorbance by reducing the results of their 
corresponding test replicates in sample antibacterial and antifungal assay plates.  
4.3.9.2   Antibacterial assay  
Bacterial susceptibility was determined according to the broth microdilution method 
(Schwalbe, et al., 2007). The bacterial strains were freshly inoculated into 50 ml of MH 
broth. The cultures were incubated overnight at 37°C in an Infors HT Multitron 
environmental shaker (United Scientific, South Africa) at 150 rpm. To obtain working 
suspensions with optical densities in the range of 0.08-0.10 which conform to 
McFarland’s constant, the absorbance of overnight starter cultures was determined 
spectrophotometrically at a wavelength of 625 nm. The absorbance of experimental 
suspensions were adjusted by dilution with MH broth. Aliquots (100 µl) of experimental 
cultures were dispensed into microtitre plates containing 100 µl samples (AgNPs; 
antibiotics) as prepared in the previous section and uninhibited growth control wells. The 
nanoparticle control plate did not receive the bacterial inoculum but rather 100 µl of fresh 
MH broth was added to each well. The microtitre plate cultures were incubated 
aerobically for 16-18 h at 37°C. Subsequently, 40 µl of freshly prepared 
iodonitrotetrazolium chloride (2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-
tetrazolium chloride, INT, 200 µg ml-1) solution was added to all wells and the plates 
incubated in the dark for 45 minutes at 37°C. The INT reagent, initially colourless, was 
reduced to a red product following incubation. This reduction was the result of persistent 
bacterial growth, whilst no colour change denoted the inhibition or lack of bacterial 
growth. The absorbance was determined at 630 nm using a multimodal plate reader 
(Biotek Synergy HT, USA) with Gen 5 software (Biotek Synergy HT, USA Ver 2.01.14). 
The experimental design included two biological replicates and in each instance three 
technical replicates per sample were used. 
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4.3.9.3   Antifungal assay  
The antifungal activity of AgNPs was determined using the broth microdilution method 
as prescribed by the NCCLS guidelines (NCCLS, 2002). Strains were inoculated into 
freshly prepared SD broth (50 ml) and grown aerobically overnight at 30°C in an Infors 
HT Multitron environmental shaker (United Scientific, South Africa) at 150 rpm. The 
cells were harvested by centrifugation at 4°C for 5 minutes at 4000 rpm and thereafter re-
suspended in 1% saline (10 ml). The absorbance of resuspended starter cultures was 
determined spectrophotometrically at 600 nm. To conform to McFarland’s standards, the 
cells were diluted using SD broth to achieve optical densities in the range of 0.08-0.10. 
Once achieved, the working suspension was diluted (1:20) in RPMI 1640 medium (with 
L-glutamine, without bicarbonate and phenol red, Biochrom, Berlin). The working 
suspension was further diluted (1:50) with RPMI 1640 to obtain the final test inoculum 
concentration of 1-5 x 103 CFU ml-1. Aliquots (100 µl) of inoculum were added to all 
wells of the test microtitre plates except the blank/negative control wells and nanoparticle 
control plate. The plates were incubated aerobically at 30°C for 16-20 h. After incubation, 
20 µl of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H terazolium salt (MTS, Promega Corporation, Madison, USA) was added to each well 
and incubated in the dark at 30°C for 4 h. Thereafter the absorbance was determined at 
490 nm. The experimental design included two biological replicates and in each instance 
three technical replicates per sample were used. 
4.3.10 Data analysis  
All data were statistically analysed using SPSS version 21. All percentage data obtained 
from the biological assays were arcsine transformed and analysed for normality (p>0.05) 
using a Kolmogorov-Smirnov test. Parametric data (which in some cases the consequence 
of transformation) were subjected to an analysis of variance (ANOVA). Differences were 
considered significant at the 0.05 level and where possible, means were separated by a 
Tukey post-hoc test. Nanoparticle size was analysed for normality as above and subjected 
to an Independent sample t-test.  
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4.4  RESULTS 
4.4.1  Bacteriocin production 
The extracellular release of pediocin PA-1 by P. acidilactici was confirmed by the 
presence of clear inhibition zones around areas spotted with CFS. Only E. faecalis 
displayed sensitivity to pediocin PA-1 (16 mm) (Fig. 4.1a) whilst no sensitivity was 
displayed by E. coli, K. pneumoniae, P. aeruginosa and S. aureus. As expected, CFS of 
B. subtilis which is a bacteriocin non-producer was inactive. The commercial antibiotic 
neomycin (200 µg ml-1) was active against E. coli (11 mm) (Fig. 4.1b), and K. 
pneumoniae (9 mm) (result not shown) whilst no inhibition was displayed against P. 
aeruginosa, S. aureus and E. faecalis. 
 
Figure 4.1 Spot-on-lawn assay plates of E. faecalis (a) and E. coli (b), respectively. 
 
4.4.2  Preparation of AgNPs from CFSs  
The reaction mixtures for AgNP synthesis from CFS of both bacterial strains initially 
displayed a faint yellow colour (Fig. 4.2a & Fig. 4.2c). Upon exposure of reaction vessels 
to direct sunlight, a brown colour immediately started to develop which signified the 
reduction of Ag+ to the resulting AgNPs (Veerasamy, et al., 2011). A maximum brown 
colouration intensity was observed at 1 hour indicating completion of AgNP synthesis 
(Fig. 4.2b & Fig. 4.2d). No colour change was observed in the negative control solution 
(result not shown).  
a b 
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Figure 4.2 Colour change of reaction solutions containing CFSs of P. acidilactici (a & b) and 
B. subtilis (c & d) with AgNO3 at 0 h and 1 h, respectively. 
 
4.4.3  Characterisation of AgNPs 
4.4.3.1  UV-Vis Spectral analysis 
The spectral profiles of both AgNP containing solutions displayed broad peaks in the 
range of 340-530 nm (Fig. 4.3). Absorbance associated at wavelengths in this range are 
typical of spherical AgNPs due to their surface plasmon (Kim, et al., 2007). Furthermore, 
broadened peaks indicated that the AgNPs are polydispersed (Peddi and Sadeh, 2015). 
There were no peaks observed for the negative control. This confirms that the CFS of 
each bacterium reduced Ag+ for the subsequent generation of AgNPs. 
a b 
c d 
1 h 
1 h 
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Figure 4.3 UV-Vis spectral profiles of AgNP containing solutions derived from CFSs of P. 
acidilactici and B. subtilis and control solution after 1 h of reaction. 
 
4.4.3.2  SEM and EDX analysis  
SEM analysis of purified AgNP mass provided a vague indication that both nanoparticle 
preparations are spherical in shape (Fig. 4.4a & Fig. 4.4c). Furthermore, the particles 
appear to be agglomerated, possibly because of the nature of sample preparation 
comprising of several centrifugation steps and their subsequent dehydration. As such, 
conclusive morphological characteristics could not be determined with SEM analysis. 
EDX spectral analysis of both AgNP preparations revealed a strong well defined silver 
signal at approximately 3 keV, typical for metallic silver (Jyoti, et al., 2016). In addition, 
weaker signals corresponding to carbon, oxygen and nitrogen were observed and they 
possibly originate from biomolecule capping structures bound to the AgNP surface (Fig. 
4.4b & Fig. 4.4d). 
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Figure 4.4 SEM images and EDX spectra of AgNPs derived from CFSs of P. acidilactici (a and 
b) and B. subtilis (c and d), respectively. 
 
4.4.3.3   TEM  
TEM analysis of AgNPs from both preparations confirmed that nanoparticles are 
spherical in shape and appear well dispersed (Fig. 4.5a & Fig. 4.5b). In addition, the 
analysis did not require samples to be subjected to physical dehydration, which as 
previously described in SEM analysis, could potentially lead to nanoparticle 
agglomeration thereby limiting their precise characterisation. Very interestingly, TEM 
analysis also revealed that the prepared AgNPs from both bacterial CFSs seem to have a 
surface coating. Size and size class distribution studies indicated narrow size distributions 
(Fig. 4.6a & Fig. 4.6b) with average diameters of 16±3.9 nm and 12±3.1 nm for AgNPs 
prepared from P. acidilactici and B. subtilis CFS (p˃0.05, t-test), respectively.  
200 nm 
200 nm 
200 nm 
a 
c 
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Figure 4.5 TEM images of AgNPs derived from CFS of (a) P. acidilactici and (b) B. subtilis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6a  Size class distribution of AgNPs derived from P. acidilactici CFS (n=100, p˃0.05 
when compared with AgNPs prepared from B. subtilis CFS, t-test). 
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Figure 4.6b Size class distribution of AgNPs derived from B. subtilis CFS (n=100, p˃0.05 
when compared with AgNPs prepared from P. acidilactici CFS, t-test). 
 
 
 
4.4.3.4   FTIR 
FTIR analysis was conducted to determine the biomolecules responsible for capping and 
subsequent synthesis of AgNPs. For the analysis, dry preparations of purified AgNPs 
were used. AgNPs prepared from CFS of P. acidilactici indicated major absorbance peaks 
at 3095; 1564 and 1400 cm-1 (Fig. 4.7a). These peaks are believed to arise from N-H 
stretching vibrations of primary amines (NH2) and secondary amines (NH) and carbonyl 
vibrations of amide Ӏ (CONH2) and amide ӀӀ (CONH) groups (Awwad, et al., 2013, 
Gomaa, 2017, Jeevan, et al., 2012). Likewise, analysis of AgNPs from CFS of B. subtilis 
indicated major peaks at 3448; 3146; 2875; 1574 and 1400 cm-1 which also correspond 
to amine and amide functional groups (Fig. 4.7b). 
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Figure 4.7a FTIR spectrum of AgNPs derived from P. acidilactici CFS. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7b FTIR spectrum of AgNPs derived from B. subtilis CFS. 
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4.4.4  Bioactivity of AgNPs 
In the current investigation, the antimicrobial effect of varying concentrations (6.25-200 
µg ml-1) of bacterial-derived AgNPs was quantitatively assessed based on the growth of 
cells treated with AgNPs in comparison to the growth of non-treated cells. Bioactivity 
was determined using the INT and MTS based microbroth dilution methods for bacteria 
and fungi, respectively (NCCLS, 2002, Schwalbe, et al., 2007). The results are presented 
in terms of the minimal inhibitory concentration (MIC) i.e. the lowest concentration of an 
AgNP solution to inhibit 80 to ˃ 80% growth of a microorganism was considered as a 
positive inhibition result.  
4.4.4.1  Antibacterial studies 
AgNP preparations from both bacterial CFSs displayed inhibition against Gram-positive 
and Gram-negative bacteria (Table 4.1). The MIC’s of the AgNP solutions ranged from 
6.25-25 µg ml-1. No significant differences were noted for the bioactivity of AgNPs 
(p˃0.05). However, a noticeable exception was observed with E. faecalis, which was 
susceptible to AgNPs prepared from P. acidilactici CFS at a two-fold decreased 
concentration when compared to AgNPs prepared from B. subtilis CFS (p˂0.05). It is 
noteworthy, that this bacterium, out of all test strains, displayed sensitivity to pediocin-
PA1. This seemingly suggests that pediocin PA-1 may be a participating capping agent 
in Ag+ reduction and subsequently enhances the bioactivity of its nanoparticle 
formulation against sensitive strains. The commercially available antibiotics: neomycin; 
ciprofloxacin hydrochloride and gentamicin displayed MIC’s ranging from 0.39 to 200 
µg ml-1 and in certain instances displayed no inhibition. Attractively, the data seems to 
suggest that in certain instances, AgNPs prepared in this study are not only more effective 
at lower concentrations but also display a broader susceptible bacterial spectrum range. It 
is worth mentioning that E. faecalis was insensitive to three commercial antibiotics but 
was susceptible to the AgNPs prepared from both CFS extracts.  
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Table 4. 1 MIC80 of AgNPs synthesised from CFSs and commercial antibiotics against 
bacterial strains 
 MIC (µg ml-1) 
Organism AgNPs from 
P. acidilactici 
CFS  
AgNPs 
from B. 
subtilis CFS 
Neomycin Ciprofloxacin 
hydrochloride 
Gentamicin 
E. coli 6.25±0.02a 6.25±0.00a 6.25±0.04 0.39±0.01 1.56±0.07 
E. faecalis 6.25±0.04a 12.5±0.02b NI* NI* NI* 
K. pneumoniae 25±0.02a 25±0.00a 25±0.04 25±0.02 6.25±0.07 
P. aeruginosa 12.5±0.02a 12.5±0.03a NI* 1.56±0.05 200±0.06 
S. aureus 25±0.02a 25±0.02a NI* 1.56±0.09 NI* 
Data are reported as the mean ± SD. Values followed by a or b superscript alphabets are significantly 
different. (p˂0.05, for AgNP preparations within each microorganism tested, ANOVA) NI = No inhibition. 
*Commercial antibiotics showed no inhibition in terms of effecting 80 % kill at their evaluated 
concentrations. 
 
 
4.4.4.2  Antifungal studies 
Three Candida reference strains were employed to evaluate the antifungal potency of the 
AgNP preparations (Table 4.2). MIC’s for AgNPs from B. subtilis CFS ranged from 6.25-
12.5 µg ml-1 whilst AgNPs from P. acidilactici CFS displayed a MIC of 6.25 µg ml-1 
across all evaluated fungal strains. The bioactivities between AgNP preparations were 
statistically significant (p˂0.05) in the case of C. albicans and C. krusei. The 
pharmaceutical bioactive amphotericin B displayed a MIC of 0.02 µg ml-1 across all 
fungal reference strains.  
 
 
Table 4. 2 MIC80 of AgNPs synthesised from CFS and a commercial antifungal preparation 
against fungal strains 
 MIC (µg ml-1) 
Organism AgNPs from P. 
acidilactici CFS 
AgNPs from B. 
subtilis CFS 
Amphotericin B 
C. albicans 6.25±0.03a 12.5±0.01b 0.02±0.00 
C. krusei 6.25±0.02a 12.5±0.04b 0.02±0.00 
C. parapsilosis 6.25±0.02a 6.25±0.01a 0.02±0.00 
Data are reported as the mean ± SD. Values followed by a or b superscript alphabets are significantly 
different. (p˂0.05, for AgNP preparations within each microorganism tested, ANOVA) 
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4.5 DISCUSSION 
AgNPs destined for antimicrobial application require processing strategies that are clean 
and economical which can be easily up-scaled for large production. To this end, the use 
of nanotechnology to formulate AgNPs from a variety of biological capping substrates 
and non-renewable energy sources are well researched (Singh, et al., 2016, Velusamy, et 
al., 2016). In this study we report on the use of sunlight, as a viable and freely available 
bio-energy resource to drive AgNP formation from bacterial capping substrates.  
Bio-reduction of Ag+ into AgNPs by biological extracts can be easily followed by a colour 
change of reaction solution to dark brown (Dipankar and Murugan, 2012). Previous 
AgNP preparation from an Enterobacteria CFS extract has been reported for its 
exceptional reduction time, with complete colour change observed within 5 minutes at 
room temperature (Shahverdi, et al., 2007). However, this largely depends on the 
mechanism of nanoparticle formation (enzyme-; protein-; or metabolite-mediated) and in 
certain instances require the use of an external energy source to drive nanoparticle 
formation. For example, Saifuddin et al., (2009) reported that maximum AgNP formation 
from bacterial CFS at room temperature occurred at 120 hours whilst the application of 
microwave irradiation substantially decreased the duration of synthesis to 3 minutes 
(Saifuddin, et al., 2009). Alternative physical parameters such as heat and agitation have 
likewise have been explored in the optimisation of AgNP production from bacterial CFSS 
(Gurunathan, et al., 2009). In this study, AgNP formation was noted at 1 hour by the 
observed colour change of reaction solutions, irrespective of the bacterial CFS used. This 
was further confirmed by the presence of absorbance peaks at wavelengths associated 
with the surface plasmon vibrations of silver particles (Kim, et al., 2007). This finding is 
in accordance with Wei et al., (2012) who used a similar approach for AgNP production 
and reported a reduction time of 80 minutes using the CFS of Bacillus amyloliquefaciens 
(Wei, et al., 2012). Our data suggests that sunlight irradiation may provide a viable 
alternative to non-renewable energy to drive AgNP formation at acceptable reaction 
times.  
Morphological characterisation by SEM analysis provided inconclusive evidence that 
AgNPs were spherical in shape, due to the degree of agglomeration observed for the 
nanoparticles. This may have been a consequence of the sample preparation required for 
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the analysis which, in previous studies, display similar inadequacies (Sadeghi and 
Gholamhoseinpoor, 2015, Sigamoney, et al., 2016). In contrast, TEM analysis displayed 
clear, unequivocal evidence that both nanoparticle preparations were spherical in shape. 
Interestingly, a previous study on the influence of AgNP shape on bioactivity suggested 
that spherically shaped AgNPs display superior antimicrobial activities when compared 
to rod shaped AgNPs (Pal, et al., 2007). Attractively, TEM analysis further revealed that 
AgNPs prepared from both CFSs were stabilised by a surface coating. It can be tentatively 
suggested that the surface coating seems important in preventing their agglomeration as 
observed from the high incidence of mono-nanoparticles. This seemingly suggests that 
biomolecule capping structures present in both CFS extracts co-function as reducing and 
stabilising agents. Interestingly, previous studies using biological substrates have also 
reported this coating phenomenon (Ezhilarasan and Sahadevan, 2011, Sigamoney, et al., 
2016). 
Intrinsically, AgNPs are highly reactive due to their nano-dimension (1-100 nm) and 
increased surface area (Christian, et al., 2008). However, it has recently been 
demonstrated that nanoparticle size alters their antimicrobial efficacies, with smaller 
AgNPs displaying superior inhibitory activities compared to larger AgNPs (Jeong, et al., 
2014, Martinez-Castanon, et al., 2008). In this study, AgNP sizes were statically 
comparable (p˃0.05) with average diameters of 16±3.9 and 12±3.1 for P. acidilactici and 
B. subtilis derived AgNPs, respectively. In addition, size-class distribution studies 
indicated that the particles possessed narrow size distributions. Previously derived AgNPs 
that were produced at room temperature from Enterobacteria CFS, displayed a size range 
of 28-122 nm with an average diameter of 53 nm (Shahverdi, et al., 2007). Similarly, 
Gurunathan et al., (2009) reported average diameter of AgNPs derived from E. coli 
supernatants to be 50 nm with size distributions of 42-90 nm. In the same study, 
application of heat to the reaction mixture initially decreased nanoparticle size, however 
at temperatures above 60°C larger nanoparticles were observed (Gurunathan, et al., 2009). 
Attractively, Wei et al., (2012) who used sunlight to drive AgNP formation, reported 
AgNPs with an average diameter of 15 nm. The findings and the data reported in this 
study strongly support the use of sunlight for the production of small sized AgNPs. 
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EDX analysis revealed that in addition to silver and although with weaker signals oxygen, 
carbon and nitrogen were present on the nanoparticle surface. Similar results were 
reported by Song and Kim (2009). It was proposed that they originate from biomolecule 
capping structures (Song and Kim, 2009). Importantly, AgNPs with oxidised surfaces 
have been reported to induce the formation of “holes” on the surface of bacteria (Smetana, 
et al., 2008), which suggests that the presence of oxygen on the surface of the 
nanoparticles synthesised here may enhance their bactericidal activity.  
FTIR analysis of AgNPs suggest that carbonyl groups of amino acids and protein linkages 
present in the CFSs have a strong metal binging ability. This may explain the presence of 
carbon, oxygen and nitrogen signals observed in EDX analysis. Consequently, it seems 
that AgNP formation occurred by the oxidation of protein molecules by Ag+ (Awwad, et 
al., 2013). Attractively, these protein molecules may be responsible for the protective 
covering observed on the surface of the nanoparticles as it has recently been suggested 
that protein capping molecules tend to form a surface coat on AgNPs which averts their 
agglomeration (Gomaa, 2017). 
The antimicrobial effects of Ag and it’s counterparts are known since antiquity (Maity, et 
al., 2011). However, these agents have limited usefulness in a biological setting due to 
the interfering effects of salts and the discontinuous release of inadequate amounts of Ag+ 
from the metal. In contrast, AgNP formulations have been shown to overcome these 
limitations and are therefore promising candidates in the development of novel 
antimicrobial agents (Kim, et al., 2007). The antimicrobial activities of AgNPs derived 
from bacterial CFS extracts are relatively unexplored in terms of their MIC values. The 
AgNP preparations of this study displayed strong antimicrobial activities irrespective of 
the bacterial extract used and are comparable to AgNPs derived from other biological 
extracts (Dipankar and Murugan, 2012). The highest MIC values in this study were noted 
for K. pneumoniae and S. aureus (25 µg ml-1) whilst E. coli displayed most sensitivity (6. 
25 µg ml-1) to both AgNP preparations. These findings are in accordance with previous 
AgNP studies in which activities for K. pneumoniae and S. aureus were either low or 
absent (Gannimani, et al., 2014, Prasad and Elumalai, 2011). Interestingly, E. faecalis 
displayed sensitivity to AgNPs prepared from P. acidilactici CFS at a two-fold decreased 
concentration when compared to AgNPs prepared from B. subtilis CFS (p˂0.05). Since 
E. faecalis initially displayed sensitivity to the pediocin PA-1 containing CFS, this may 
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tentatively suggest that pediocin PA-1 probably participated in Ag+ reduction and in so 
doing enhanced the bioactivity of its nanoparticle formulation. Importantly, this organism 
displayed resistance to all three commercial antibiotics and has previously been reported 
for its intrinsic resistance and further acquisition of resistance genes leading to the 
emergence of E. faecalis as a nosocomial pathogen that is a refractory to most therapeutic 
agents (Paulsen, et al., 2003). Furthermore, the conjugative transfer of high levels of 
resistance genes from E. faecalis to S. aureus has been long established and may probably 
explain the increased incidence of S. aureus resistance to both neomycin and gentamicin 
in this study (Noble, et al., 1992).  
Both AgNP preparations displayed good antimicrobial activities against fungal strains 
with MIC values of 6. 25 µg ml-1 for AgNPs from P. acidilactici CFS and 6.25-12.5 µg 
ml-1 for AgNPs from B. subtilis CFS. The difference in MIC’s is at present unclear and 
further studies need to be conducted to determine if capping structures present in the CFS 
constitute to the marked difference in bioactivities. These findings are in contrast to what 
has been suggested by Nabikhan et al., (2010), that AgNPs are better antibacterial agents 
rather than antifungal agents. This notion was supported by the finding that AgNPs are 
able to freely adhere to and penetrate bacterial cells, whilst they are unable to enter fungal 
cells at low concentrations (Nabikhan, et al., 2010). The AgNPs produced in this study 
show no alteration in bioactivity between bacterial and fungal organisms, suggesting that 
their mode of action remains unaffected by the difference in the cell wall structures of 
these organisms. Importantly, AgNPs produced in this study display bioactivities at 
concentration doses that are generally associated with limited or no cytotoxic potential 
(Dipankar and Murugan, 2012) and therefore provide promising broad-spectrum 
antimicrobial alternatives to orthodox antibiotics which may provide much needed relief 
to the health care delivery system. 
 
4.6 CONCLUSION 
Nanotechnology provides a much needed platform for the development of new or 
improved antimicrobial agents. Physical characteristics of AgNPs such as shape and size 
are critical in the development of low concentration dose bioactive pharmaceuticals. The 
use of sunlight irradiation for AgNP production from P. acidilactici and B. subtilis CFSs 
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produced nanoparticles with desired physical attributes at favourable reaction times. 
Furthermore, capping structures present in the CFSs advantageously reduced Ag+ and 
stabilised the resultant AgNPs. Importantly, AgNPs displayed excellent antimicrobial 
activities and thus represent as promising novel Ag-based antimicrobial agents as 
alternatives to current antibiotics. For future studies, it would be interesting to isolate 
pediocin PA-1 and other bacteriocins from culture supernatants so as to explore their 
potential as a capping agents for development of novel AgNPs.  
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5.1  GENERAL DISCUSSION AND CONCLUSION 
The development of novel antimicrobial therapeutic agents is a cumbersome, expensive, 
yet unavoidable exercise. On average, it takes at least a decade for a novel antimicrobial 
agent to succeed clinical trials and reach the market (Hughes, et al., 2011). This may be 
owing the number of unwanted side effects exerted by a drug or the risk of antimicrobial 
resistance development. The use of nanotechnology to generate nanoparticulate forms of 
silver for antimicrobial applications is rapidly emerging into an important branch of 
science and technology (Sharma, et al., 2009). In this regard, concerted research iniatives 
are being made in terms of identifying green synthetic strategies with optimal reaction 
conditions and novel capping agents for the production of AgNPs with enhanced 
bioactivities (Hazarika, et al., 2016).  
The first aspect of this study reports on the formulation AgNPs using freeze-dried and 
fresh leaf extract preparations of the medicinal tree species M. oleifera in a green synthetic 
protocol wherein sunlight irradiation was used to drive nanoparticle formation. AgNPs 
were produced equally well from both leaf samples and were comparable in terms of their 
morphology, yield and bioactivity. Attractively, capping structures identified to be 
flavones, terpenoids and polysaccharides in the leaf biomass displayed a dual role of 
reducing Ag+  and stabilising the resulting nanoparticles. Importantly, AgNPs displayed 
good antimicrobial activity against bacterial and fungal strains and in certain instances 
outperformed commercial antibacteral pharmaceuticals. It seems that AgNPs in this study 
were produced by a more efficient green technology, in addition this is the first report on 
the characterisation of M. oleifera leaf derived AgNPs in terms of their minimal inhibitory 
concentrations.  
For the second aspect of the study, novel AgNPs were produced from bacterial extracts 
using the same energy source as mentioned above. AgNPs were prepared from the cell 
free supernatant of the bacteriocin (pediocin PA-1) producing strain, P. acidilactici and 
evaluated against AgNPs from the non-bacteriocin producing B. subtilis strain. The 
results suggest that for both AgNP preparations, protein capping molecules in the 
bacterial extracts were responsible for the formation and subsequent stabilisation of the 
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particles. AgNPs were generally consistent in terms of their morphology and bioactivity. 
However, it was noted with regard to E. faecalis that AgNPs produced from the 
bacteriocin containing extract displayed a two-fold increase in bioactivity when compared 
to AgNPs prepared from its non-bacteriocin containing counterpart. Since this strain 
initially displayed sensitivity to the pediocin PA-1 containing CFS, it is tentatively 
suggested that pediocin PA-1 probably participated in Ag+ reduction and in so doing 
enhanced the bioactivity of the nanoparticle formulation. Nevertheless, both AgNP 
samples showed good antimicrobial activities and in some instances, at concentrations at 
which the commercial antibiotics were inactive.  
The results attained in this study suggest that sunlight irradation provides a viable 
alternative to the use of non-renewable energy sources for production of attractive 
AgNPs. Interestingly, using this energy source, production of AgNPs from extracts of 
two different phyla closely mirrored each other and were consistent in terms of their 
reduction time, morphology, stability and antimicrobial-spectrum range. These findings 
and previous reported findings seemingly suggest that the use of sunlight may be applied 
for the production of uniform AgNPs even from different capping substrates 
(Annadhasan, et al., 2012, Karimi Zarchi, et al., 2011, Rastogi and Arunachalam, 2011). 
Therefore, this method represents an attractive alternative to current nanoparticle syntheic 
routes which is cost-effective, eco-friendly and facilitates easy up-scaling for large 
production. Furthermore, with their observed antimicrobial potential, AgNPs dervied in 
this study contribute to the search for novel antimicrobial agents. 
For future studies, it would be interesting to isolate pediocin-PA1, and other bacteriocins 
and assess their ability as Ag+ capping agents. Futhermore, the bioactivities observed in 
this study indicate that the derived AgNPs serve as promising antimicrobial alternatives 
and therefore warrants their cytotoxic screening. South Africa is blessed with an extensive 
indigenous flora used by traditional medicine and the nanoparticle synthetic strategy 
herein provides an attractive avenue for their protential development into antimicrobial 
AgNPs. 
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